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Qualitative and quantitative analysis through digital imaging has significant 
potential in several scientific applications including bioanalytical applications. In 
this document, the implication of digital imaging to validate and characterize a 
novel microfluidic organ-on-chip device and establish a point-of-care method to 
estimate epinephrine concentrations in expired and degraded autoinjectors have 
been described in chapter 2 and 3 respectively. Chapter 4 includes description of 
the principle and methodology of strong cation exchange-based immunoassay for 
oxytocin and β-endorphin.  
In chapter 2, fabrication of a novel microfluidic organ-on-chip device capable of 
culturing rodent SCN slices has been discussed. Characterization of the aCSF 
media droplets and carbogen gas bubbles have also been discussed. Viability of 
the cultured rodent brain slices using digital imagery through fluorescence calcium 
imaging and PI/DAPI staining have been reported. In chapter 3, utilization of 
quantitative smartphone imaging to estimate the concentration of epinephrine in 
expired and degraded autoinjectors have been described. Actual concentrations 
of the samples have been established by UHPLC technique. The estimated 
concentrations of the samples via quantitative smartphone imaging have been 
reported to possess a strong correlation (r > 0.7) with the actual concentration. 
Different lighting conditions, distance and angle of camera variations have been 
explored in chapter 3.  
Direct immunoassay of relatively small neurotransmitters (~1-5 KDa) through 
capillary electrophoresis is prone to poor resolution challenge. The principle of 
using strong cation exchange-based chromatography to carry out such 
immunoassays have been described in chapter 4. The possible use of crosslinking 
agents such as sulfo-GMBS and sulfo-SMPB to improve antigen-antibody binding 
has also been discussed in this chapter. Chapter 5 explores the future directions 
of improving the rodent slice culture device to accommodate various size and 
shape of brain slices by chamber geometry and surface energy optimization.  
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1.1 Background concepts on microfluidic 
approaches to brain slice culture 
1.1.1 Objective 
The tissue-on-a-chip approach for rodent brain culture is an emerging field of 
research in ex vivo modeling of neurobiology. Tissue-on-a-chip can offer online 
measurements of tissue secretions and integration to sophisticated analytical tools 
for selective and sensitive measurement. This approach also minimizes bio-waste 
and limit reagent usage promoting greener techniques. The project described in 
chapter 2 aims to achieve a microfluidic slice culture device which can complete 
the following goals: 1. Mimicking roller tube slice culture method in microfluidic 
platforms, 2. Maintaining slice viability for short to long term experiments, and 3. 
Establishing a platform to be integrable to analytical instruments for selective and 
sensitive measurements of tissue secretions.  
Completing these goals will result in exploiting the benefits of the roller tube 
slice culture method in addition to the benefits of the microfluidic platform. The 
roller tube method, described below, is known for better oxygenation of the slice 
resulting in prolonged slice viability. A slice viable for days to weeks can be ideal 
candidates for studying the secretion profiles to investigate the tissue’s circadian 
characteristics or response to external stimuli. Integration of analytical instruments 
will enable studying upregulations or downregulations of cellular secretions due to 
external or internal stimuli in real time with high spatial and temporal resolution. To 
be able to complete these goals, a microfluidic flow device needs to be developed 
with precise control over the fluid flow and oxygen delivery. Proper housing of the 
slice with sufficient tissue adhesion is essential to withstand the stress from the 
fluid flow. The viability of the cultured tissue slice needs to be confirmed via 
techniques such as calcium imaging and PI/DAPI staining of the cell nucleus. 
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1.1.2 Roller tube method for rodent brain slice culture 
Culture experiments of brain slices are a common practice in neurophysiology 
to study basic mechanisms of the brain [1-3]. A slice of the area of interest of an 
animal brain isolated for experiments require constant nutrients and oxygen supply 
due to the absence of the normal supply. Neuronal cells have an above average  
oxygen demand to thrive [4] and hence require continuous oxygen supply. There 
are numerous approaches for tissue perfusion described in the literature and they 
can be broadly classified to two categories [5]. In the first category, brain slices are 
submerged in oxygen rich artificial cerebrospinal fluid (aCSF). In the second 
category, brain slices are placed on an interface above aCSF with oxygen rich 
surroundings. In both categories, nutrients and oxygen penetrate the slice by 








A roller tube approach can be labeled as a combination of these two categories 
where the slice is adhered to a substrate placed inside a tube partially filled with 
aCSF and oxygen rich air [6]. The tube rotates along with the substrate and as a 
result, the slice is alternatively submerged into the aCSF and exposed to the 
oxygen (Figure 1) This approach allows maximum surface area of the slice to come 
into contact to both aCSF and oxygen in contrast to the other approaches. All these 
approaches are often used in experiments involving the measurements of the cell 
potentials related to neurophysiological activities [7]. The aCSF collects molecules 
secreted from the brain slice when in contact. Periodically analyzing the aCSF can 
potentially be important in studies of the secreted molecules and their response to 
outside stimuli. However, the concentration of the molecules of interest would be 
diluted to multiple orders of magnitude compared to in vivo concentrations due to 
the very low amounts of such secreted analytes [8] and the use of comparatively 
large volumes (mL) of the aCSF. The detection limits and the sensitivities of many 
common analysis techniques may not be suitable for such analyses. The 
measurements of analytes in the aCSF will not provide highly resolved temporal 
information since the media solution cannot be replaced in very short time 
intervals. To overcome these challenges, a microfluidic mimic of the roller tube 
approach is developed in chapter 2 of this dissertation. Although secretion 
measurements have not yet been demonstrated in this system, it is designed to 
limit the dilution of secreted analytes and offer secretion measurements highly 
resolved in the time domain.  
The roller tube method has extensive applications reported in the literature 
where rodent brain slices had been viable for a few day days to a few months. 
Ostergaard and co-workers have applied the roller tube slice culture method to 
investigate tyrosine hydroxylase which is a biomarker of dopaminergic neuron and 
fibers. The method was successful in culturing the slices for up to 60 days which 
demonstrates the effective nutrient and oxygen delivery approach [9]. Roller tube 
method has also been reported to successfully culture sagittal cross-section of 
whole rodent brain slices to investigate cholinergic and dopaminergic neurons, 
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effect of pathological triggers such as hydrogen peroxide on the dye stained nuclei, 
and factors contributing to Alzheimer’s and Parkinson’s disease [10]. Rodent brain 
tissue slices containing suprachiasmatic nuclei (SCN) have been studied in 
cultures modeled in roller tubes multiples times by several groups [11-14]. The 
circadian rhythm of rodent SCN is well-established and current topic of research 
by many scientists [15-17]. Studying rodent brain slices containing SCN by novel 
approaches will allow comparative studies and enable validation. Calcium 
response in SCN slices can be impacted by implementing receptor associated 
proteins (RAP). RAP acts as LDL inhibitors [18] which in result is hypothesized to 
suppress calcium responses in SCN slices stimulated by high concentration of 
potassium solution. SCN slices can be incubated with RAP to assess the 
suppression/recovery of the calcium responses due to LDL inhibition. The 
perfusate in the form of droplets will be collected to study the SCN secretion profile 
such as vasopressin and vasoactive intestinal peptide through mass-spectrometry. 
The perfusate droplets can also be investigated for ATP molecules through 
chemiluminescence. Mimicking of the roller tube method with microfluidic 
approach may bring new possibilities for microscopy and analysis of secreted 
molecules. This innovation has potential to address several analytical challenges 
of investigating regulation of hormones by improving measurement sensitivity and 
temporal resolution.  
1.1.3 Microfluidic brain slice culture 
Microfluidic devices for brain tissue culture is a significant improvement from 
conventional interface and submerged techniques. Microfluidic approaches for 
tissue culture can improve the penetration of oxygen and nutrients to the slice, 
enhance spatial and temporal resolution of measured responses by providing 
better controllability over the fluid flow, and widen the horizon of tissue experiments 
by opening up the opportunities of integration of modern microscopic and 
electrophysiological methods for improved experiments [19]. In vitro experiments 
on cultured brain cells offer a lot of opportunities to study cellular mechanisms of 
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neurobiology, but such approaches typically fail to provide accurate models of 
specific brain regions, processes, and neural connections. A brain slice harvested 
from an animal immediately after decapitating it can be preserved by providing 
necessary nutrients and oxygen [20], and preserves cytoarchitecture, neural 
connections, and other important features not found in cell culture models.  
Microfluidic approaches to brain slice culture can improve the oxygen and 
nutrient penetration by introducing interstitial flow. Interstitial flow of fluids through 
the slice can enable culturing thicker slices which can offer better preservation of 
the cytoarchitecture. Brain slices can be fixated inside microfluidic devices by 
anchor posts creating interstitial pathways. Laminar flow of nutrients can be guided 
through these pathways for better penetration of the nutrients [21, 22]. Another 
approach for introducing the interstitial flow is to utilize the Bernoulli effect. The 
slice will be place inside a microfluidic device in between an upper and a lower 
channel. The flowrate of the nutrient fluid will be faster in the lower channel and 
slower in the upper channel. There will be a pressure gradient between the 
channels which will make the fluid flow through the interstitial space of the slice 
from the slower fluid flow channel to the faster fluid flow channel [23]. Figure 2 
illustrates an example of a microfluidic device for brain slice culture involving 
interstitial fluid flow. By carefully designing the shape and size of microfluidic 
channels, fluid flow manipulation can be implemented to treat different regions of 
the slice according to the necessity of the experiments. The spatial resolution of 
the tissue responses can be significantly improved in the microfluidic approach [24, 
25]. Contrarily, in the conventional techniques the spatial resolution of the tissue 
responses is limited by the size of the entire tissue. Similarly, the temporal 
resolution of the tissue responses in the microfluidic approach can be improved 
since it inherently involves low fluid volumes [19]. Small volumes of fluid can entrap 
cellular secretions without any significant dilution effect which can improve any 
measurement sensitivity afterwards. Frequent exposers of small droplets to the 
slice can notably improve the temporal resolution of subsequent measurements, 








Microfluidic slice culture devices enable integration of techniques like 
microscopy and electrophysiology. Neuroscientists are interested in all regions of 
the brain, and although stereotaxis allows electrical and fluidic probe insertion to 
deep brain regions, in vivo experiments do not allow easy microscopic 
observations to the internal regions. Contrarily, brain slices cultured in microfluidic 
devices expose the internal regions including neural connections on the surface to 
be easily observed. Additionally, microfluidic devices are often prepared with 
optically transparent materials which enables integration of microscopy technique 
with proper magnification. The integration of electrophysiological methods to the 
microfluidic slice culture devices are reported to be more challenging, but several 
research groups have addressed the issue. Open access microfluidic devices have 
been developed to allow probes to access the slice through removable parts of the 
device [27]. Other microfluidic approaches include microelectrode arrays 
embedded within the device for recording electrophysiological responses with 
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spatial resolution [28, 29]. Such approaches have been used for reestablishing 
neural connections between two physically isolated brain slices [30] and 
recuperating medullary slices which can be used to initiate breathing activity if 
connected to a functionable lung [31, 32]. 
Numerous novel directions and improvements of conventional slice culture 
techniques provided by the microfluidic approach can also present some 
limitations. Fluid flow inside microfluidic channels may introduce shear stress to 
the slice resulting in displacement and damage [33]. Such experiments require 
careful consideration in regulating the fluid flow rate to avoid fatal shear stress. 
Microfluidic channels are known to hold on to small gas bubbles at the corners and 
channel walls where salt residue from earlier experiments may remain. Thorough 
cleaning in between experiments are essential to avoid the gas bubble issue [34]. 
Another limitation of the microfluidic slice culture devices can be the use of PDMS 
as a fabrication material. PDMS is known to absorb small hydrophobic molecules 
which may interact with subsequent experiments [34]. Disposable PDMS devices 
can be a possible solution for this issue since replication of PDMS microfluidic 
devices is generally not complex and inexpensive.  
1.1.4 Monodispersed bubble and droplet generation 
Monodispersed refers to having uniform sizes. Working with monodispersed 
bubbles and droplets in microfluidics enable uniform volume characteristics in 
applications such as material synthesis [35-37], chemical synthesis [38], drug 
formulation [39], and fluid dynamics [40, 41]. Generating monodispersed bubble 
and droplets for microfluidic brain slice culture can greatly improve the analysis of 
the secreted molecules. To be able to accurately measure the contents of droplets 
which have interacted with the brain slice, control over the dimensions of the 
bubbles and the droplets is essential. Since the channels of typical microfluidic 
device have uniform width and depth, the volume of the droplets and bubbles will 




Figure 3: Monodispersed carbogen bubble and aCSF droplet 
generation at a microfluidic T-junction 
 
 
other factors such as mixing time, dispersion time, and sample volume [42]. The 
length of the bubbles or droplets can be described according to equation 1 [43]. 
𝐿
𝑤




Here, L is the length of the bubble or droplet, w is the width of the microfluidic 
channel, Qdisp and Qcont are the flowrates of the dispersed and continuous phase 
respectively, and α and β are channel geometry dependent constants. The values 
of these constants are in the order of 1. Gas phase fluids can be dispersed to a 
continuous flow of liquid resulting in alternative gas bubbles and media droplets a 
microfluidic device [44]. The flow of both the phases come into contact of each 
other in a T-junction and the continuous phase would squeeze the disperse phase 
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leading to the bubble generation. The alternate gas bubbles and liquid droplets 
can be composed of carbogen (95% O2 and 5% CO2) gas and aCSF media 
respectively and would be passed over an SCN slice placed in a chamber 
downstream of the T-junction.(Figure 3) The aCSF droplets on the other side of 
the chamber would possibly contain secreted molecules from the SCN slice and 
can be analyzed for further investigations. The concentration of the analyte of 
interests would be minimally diluted since a single droplet volume would be in the 
low µL regime and would not come into contact of other droplets due to the 
segmentation by gas bubbles. The measurements will have temporal resolution 
dependent on the frequency of droplets coming into contact of the SCN slice. 
1.1.5 Tissue adhesion 
Tissue adhesion is a critical barrier to perform slice culture using the roller tube 
method. Without adequate tissue adhesion, brain slices in the culture container or 
device can be displaced by container movement or fluid flow in the microfluidic 
channels. Tissue adhesion approaches retain the slices in the desired positions 
for proper nutrient delivery and observing tissue responses due to experimental 
stimulations. There are several approaches for adhering brain slices during culture 
in either conventional or microfluidic methods. In this dissertation, two different 
approaches will be discussed which are namely, physical, and chemical 
approaches.  
Physical approaches of tissue adhesion involve including physical anchors in 
the culture container or device. In microfluidic slice culture devices, such anchors 
can easily be fashioned and attached. In some cases, the anchors can be 
fabricated as components of the microfluidic device. The physical approach can 
be very effective in holding on to the slice and usually tolerant to significant amount 
of shear stress without displacement. But physical approaches have limitations 
which may not be ideal for specific experiments. Introducing an extra component 




Figure 4: An example of the physical approach of tissue adhesion 
 
 
surface energy inside the microfluidic device may alter due to added anchors which 
may disrupt the fluid flow. Moreover, the anchor itself may put stress on the slice 
resulting in damage and disrupt the experiment. In Figure 4, an example of the 
physical approach of tissue adhesion is demonstrated. The fashioned hook is seen 
to cause entrapment of an air bubble interrupting usual fluid flow. Several other 
similar examples are shown in appendix A (Figure 31). 
Using plasma clot as an adhesive material is well studied and widely reported 
in the literature as a chemical approach for tissue adhesion [21, 45-47]. Blood 
plasma contains fibrinogen which acts as a blood coagulating agent in vertebrates 
[48]. Fibrinogen is produced in the liver and gets circulated to the entire body 
through blood circulatory system. In the presence of thrombin enzyme, water 
soluble fibrinogen converts to water insoluble fibrin [49]. The conversion process 
is rapid, as a result precise transfer protocol needs to be maintained to attach the 





Figure 5: Incapability of plasma clot as an adhesion approach for  
the microfluidic bubble perfusion device 
 
 
process adheres the slice to the surface and disallows displacement during 
container movement or fluid flow in the microfluidic channels. While plasma clot 
approach has been proved to be successful in numerous brain slice culture studies 
for tissue adhesion, the retaining capability was unable to withstand the shear 
stress (Figure 5) in the microfluidic experiments described in chapter 2. For the 
purpose ensuring adequate tissue adhesion for the project described in chapter 2, 
a stronger adhesive compound was required. 
Nontoxic and bio-degradable adhesive material is also a matter of interest to 
medical surgeon’s which can be used as an alternative approach to sutures. A 
significant body of research exists to develop and implement such adhesive 
materials in the surgery process [50-55]. Balakrishnan and co-workers have 




Figure 6: Reaction schematic of the hydrogel based  
tissue adhesive material [56] 
 
 
to be non-toxic and bio-degradable [56]. Chitosan treated with HCl was combined 
with dextran dialdehyde to form the hydrogel based adhesive material (reaction 
scheme in Figure 6). The novel adhesive material was extensively studied to 
observe the non-toxicity, biocompatibility, and biodegradability. In addition to 
perform all the said functions, the novel adhesive material also has hemostatic and 
drug carrier capabilities which can be very useful in surgery applications. The 
material also remains simple and inexpensive to synthesize. This novel adhesive 
material was used as a tissue adhesive in all the perfusion experiments described 
in chapter 2. The SOP of synthesizing the adhesive is in APPENDIX B. 
1.1.6 Brain slice viability in the perfusion experiments 
A fluorescent calcium imaging technique was utilized to confirm slice viability 
in the experiments described in chapter 2. Intracellular [Ca2+] is correlated to 
physiological and pathological activity of neurons [57]. Ca2+ acts as a messenger 
in the cellular level triggering physiological activities such as proliferation, 
migration, survival, and apoptosis [58-60]. Typical intracellular [Ca2+] falls in the 









(VGCC) in neuron cells are Ca2+ permeable [62]. Generally, cells in higher 
organisms possess a internal net negative charge in reference to the outside 
environment. Depolarization is a process when the net internal charge transforms 
to a temporary positive phase. The VGCCs open for Ca2+ during depolarization of 
the cell membranes. Influx of positive charges like K+ can depolarize the cell 
membrane initiating the opening of the VGCCs. As a result, the intracellular [Ca2+] 
increases. Subsequent repolarization of the cell membrane reestablishes the 
resting period of the cells. Fluo-4 AM is a cell membrane permeable dye. The 
acetoxy methyl ester groups present in the dye molecule mask the charged nature 
to make it membrane permeable [63]. An SCN slice can be loaded with the dye 
before placing in the microfluidic perfusion device. The loading process needs to 
occur for a minimum 1 hour for rodent brain slices while maintain the proper 
nutrient and oxygen supply. The masking groups in the Fluo-4 AM dye gets 
hydrolyzed inside the cells in the presence of esterase enzyme and Fluo-4 AM 
converts to a cell impermeable Fluo-4 dye. Figure 7 shows the principle of calcium 
imaging. 
Periodical stimuli of K+ to the SCN slices will depolarize the cell membranes 
resulting to increase intracellular [Ca2+]. Ca2+ binds to Fluo-4 forming a fluorescent 
complex (λex 488 nm and λem 515 nm) [64]. Measuring the fluorescence following 
a K+ stimulus can confirm intracellular Ca2+ activity and hence confirm the viability 
of the SCN slice in the microfluidic perfusion device. To measure the fluorescence 
of the Ca2+ and Fluo-4 complex, the dye loaded brain slice needs to be irradiated 
with a light source. The incident light should be passed through a bandpass filter 
allowing 488 nm wavelength to pass. The fluorescence light should be passed 
through a bandpass filter allowing the 515 nm wavelength to pass and be recorded. 
Depolarization of cell membranes can increase [Ca2+] 10x which enables 
significance change in the fluorescence activity [61]. 
Propidium iodide (PI)/Diaminophenylindol (DAPI) (structures in Figure 8) 




Figure 8: Molecular structure of a. propidium iodide,  
b. paraformaldehyde, and c. diaminophenylindol 
 
 
slices used in the experiments described in chapter 2. PI and DAPI are commonly 
used dyes for nucleus staining. Both PI and DAPI dye is permeable to dead cells 
due to damaged cell membrane. PI molecules interact inside the double helix DNA 
of nucleus and DAPI is known to bind itself to the minor groove of the double helix 
DNA. Both the molecules fluoresce after interacting with the cell nucleus 
components.  These dyes can be used to determine the viability of a rodent brain 
slice by utilizing the fixation method. Fixation of cells implies preservation of bio-
tissues because of degradation due to internal enzymes or external factors. 
Paraformaldehyde (PFA) is a widely used cell fixation agent. The rodent brain 
slice can be treated with PI prefixation to stain the dead cells at a given time point. 
Post treatment with PI dye, the slice can be treated with PFA for fixation to take 
place. During fixation, PFA modifies the amino acids and peptide bonds by adding 
sidechains which results to protein stabilization and the morphology of the slice is 
preserved. The DAPI staining of the nucleus of the cells must follow the fixation 
process [65]. The cells inside a fixed tissue slice are not viable, so DAPI can 
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penetrate them through the damaged cell membrane. The PI stained cells before 
fixation will appear magenta and all the DAPI stained cells which were not stained 
by PI dye will appear blue. The ration of these colored cells can be used to 
determine the viability of the tissue slice before fixation. 
1.1.7 Summary 
Background concepts pertaining to our microfluidic approach for mimicking 
roller tube tissue culture method are described. The mechanism of monodispersed 
bubble generation in a microfluidic T-junction is discussed. Proper tissue adhesion 
protocol and appropriate slice viability confirming experiments are also outlined in 
this section.  
1.2 Background concepts on quantitative 
smartphone imaging for epinephrine dose 
estimation 
1.2.1 Objective 
The price of commercial epinephrine drugs has increased 10-fold since 2009 
[66, 67]. This increase in price has encouraged the tendency of not replacing 
expired epinephrine among patients [68, 69]. In addition to that, lack of proper 
storage degrades and discolors the epinephrine. Doctors and manufacturers 
discourage using expired and degraded epinephrine. In the practice of austere 
medicine or wilderness medicine, fresh supply of epinephrine is scarce and the 
unpredictable weather in the remote places may not offer proper storage for the 
medicine. In such circumstances, the only possible way to treat an anaphylactic 
patient with an expired and/or degraded epinephrine auto-injector.  
Presence of epinephrine in expired autoinjectors is established in the literature 
[70]. But study with degraded autoinjectors is absent, and a point-of-care 
estimation method is not established. In this project, we aim to study primarily 
expired autoinjectors. We also aim to establish a quantitative smartphone imaging-
18 
 
based point-of-care epinephrine concentration estimation method for degraded 
autoinjectors. The project takes several possible imaging conditions into account 
before establishing the quantitative method. We also focus on achieving a narrow 
confidence interval band for the concentration estimation near the standard 
epinephrine dosage. The success of the project can be helpful for medical 
professionals in their decision-making process of using an expired and degraded 
epinephrine autoinjector during an emergency when no other viable alternative is 
not available. We do not advocate using expired autoinjectors in this project. The 
wider medical community is more knowledgeable and better equipped to make that 
decision. This project only intends to offer an estimation tool for emergency 
circumstances. 
1.2.2 Anaphylaxis 
Anaphylaxis is a medical condition which exerts hyperallergic reactions in the 
patient affecting multiple parts of the organ system. The condition may be triggered 
by external stimuli such as food, medicine, and envenomation. The most common 
symptoms of anaphylaxis include itchy rash, swelling of throat area, difficulty in 
breathing, vomiting, weakness, and abnormal blood pressure.  
The mechanism of anaphylactic shock in the human body is initiated by abrupt 
secretion of mast cells and basophil-derived mediators into the blood circulatory 
system [71]. The mechanism is classified into two categories, namely Immunologic 
or non-immunologic. The immunologic mechanism can either be IgE-dependent or 
IgG-dependent [72]. The mechanism pair is widely studied on rodent systems and 
is speculated to be applicable to human systems in a similar manner [73]. In the 
IgE-dependent mechanism, allergen induced cross-linking of high-affinity 
receptors from mast cells and basophils cause the release of inflammatory 
mediators and cytokinesis. This event leads to increased vascular permeability and 
smooth muscle contraction [74, 75]. The stated conditions are strongly associated 
with anaphylaxis. The IgG dependent mechanism involve macrophage and require 
a larger amount of antibody-antigen activity [75-78]. Platelet activating factor which 
19 
 
is responsible for initiating blood clot is released in both the mechanisms resulting 
in increasing risk for the patient. The non-immunologic mechanism is triggered by 
external factors such as extreme temperatures, substance use, and use of certain 
anti-biotics which may dysregulate the mast cells and the basophils leading to 
anaphylaxis. This mechanism does not involve any immunological molecule [75, 
78]. 
The trigger factors of anaphylaxis can be identified in many sources. Some 
common food sources responsible for anaphylaxis are nuts, gluten, shellfish, dairy, 
and beans. Penicillin, aspirin, vancomycin, morphine, selected cancer drugs, and 
vaccines are some of the common medication sources responsible for 
anaphylaxis. Stings from ants, bees, wasps, and kissing bugs are known 
envenomation sources responsible for anaphylaxis. Atopic disease patients such 
as patients suffering from asthma, eczema, and allergic rhinitis bear a higher threat 
of an anaphylactic attack due to exposure of any of the triggers.  
The diagnosis of anaphylaxis is primarily dependent on the symptoms of the 
patient. The exposure to an allergen leading to two or more symptoms of 
anaphylaxis may be an initial indicator. Presence of histamine in blood may confirm 
anaphylaxis if triggered by medicine or envenomation but remains inconclusive if 
triggered by food [73]. Other medical conditions such as asthma, syncope or panic 
attacks may have overlapping symptoms but can be segregated by the presence 
of itching and gastrointestinal symptoms in case of anaphylaxis. 
Approximately 2-5% of the population get anaphylactic attack in the USA each 
year and approximately 1000 people die as a result [79]. Anaphylaxis can be 
prevented by avoiding exposure to known allergens. An anaphylactic episode 
should be addressed by an anti-allergen drug at the earliest to mitigate 





Epinephrine or Adrenaline (Figure 9) is a hormone produced in the adrenal 
glands and medulla oblongata. It is widely used as a treatment for anaphylaxis. 
The pharmacology of epinephrine allows it to alleviate the severe effects of 
anaphylaxis. Epinephrine binds to at least two receptors, termed alpha, and beta. 
The binding of epinephrine with alpha receptors decreases peripheral vasodilation 
which helps reduce elevated blood pressure, erythema, urticaria, and angioedema 
[80]. The binding of epinephrine with beta receptors causes bronchodilation to help 
breathing problems and suppress mast cells and basophils release [80]. As a 
result, epinephrine can treat abnormal blood pressure by enhancing blood flow, 
difficulty in breathing by loosening muscles in the lungs system, and blocking 
allergic reaction initiating cells. Therefore, epinephrine is considered the most 




Figure 9: Molecular structure of epinephrine 
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Delay in administering epinephrine is correlated with poor performance of the 
drug by achieving delayed plasma peak concentration [81, 82]. Other reasons for 
poor performance of the drug include underlying diseases of the patient, lack of 
sufficient available dose of epinephrine in the drug, and presence of systematic 
disorders in the patient. Epinephrine is reported to have a very narrow therapeutic 
window [80]. Administering lower amount of epinephrine to the patient will have no 
significant benefit, and on the other hand overdose of epinephrine have 
occasionally led to myocardial infraction or ischemia, pulmonary edema, 
accelerated hypertension, and intracranial hemorrhage. Common side effects of 
epinephrine include palpitations, headache, anxiety, pallor, agitation, and 
dizziness [80]. Cross-interactions of epinephrine with beta adrenergic blocker 
medicine is known and therefore interference with intrinsic compensatory 
responses to hypotension occurs [80].  
Several routes of administration of epinephrine into patients are practiced in 
the medical community such as intramuscular, intravenous, and inhalation. 
Though the intramuscular route is the most used, some medical professionals 
recommend an inhalation route or an intravenous route for unresponsive patients 
[80]. Though there is a lack of comparative study on different routes due to inability 
of conducting research on anaphylactic patients. In this work, epinephrine samples 
studied are collected from EAIs which were intended only for use through 
intramuscular route.  
1.2.4 Epinephrine measurement by UHPLC 
The drug formula for commercial EAIs contain several inactive ingredients 
along with epinephrine. According to the product literature of EpiPen, the inactive 
ingredients are sodium chloride, sodium metabisulfite, hydrochloric acid, and 
water. Due to degradation and discoloration, several other melanin-like 
compounds form in the solution [83, 84]. To measure epinephrine in such complex 
solution, separation-based quantification method can be successful. To determine 
the available dose of epinephrine, the analyte must be separated from the 
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degraded compounds and other inactive ingredients. Consequently, reverse 
phase liquid chromatography was chosen as a functional quantification technique 
to measure available epinephrine dose in expired and degraded EAIs. 
In liquid chromatography, a column packed with solid particles as stationary 
phase and a liquid flow through the column as mobile phase are used. In reverse 
phase liquid chromatography, the stationary phase particles are hydrophobic. The 
mobile phase used is a purely hydrophilic liquid or a mixture of both hydrophilic 
and hydrophobic liquids. The percent composition of the mobile phase can be 
manipulated to control the elution profile and achieve better separation of the 
analytes. The sample containing the desired analyte is injected to the column along 
with the stream of the mobile phase. The analyte will be adsorbed by the stationary 
phase particles along with the other compounds in the sample. By continuing the 
flow of the mobile phase and changing the polarity of the mobile phase, all the 
adsorbed molecules will elute the column based on the polarity. The more polar 
molecules will elute faster because of less interaction with the hydrophobic 
stationary phase and the less polar molecules will elute slower because of more 
interaction with the hydrophobic stationary phase. Decreasing the polarity reduces 
the analyte-stationary phase interaction, and as a result also aids the elution of the 
less polar molecules. The elution time also depends on the particle size and the 
pore size of the particles. The basic principle of the reverse phase liquid 
chromatography is depicted in Figure 10.  
The efficiency of chromatographic separation is dependent on the resolving 
power of the column. Number of theoretical plates are correlated with the column 
resolving power. Theoretical plates are hypothetical zones in a chromatographic 
column where different phases are in equilibrium with each other. The resolving 
power of a column is proportionally related with the number of theoretical plates. 





Figure 10: Reverse phase liquid chromatography 
 
 




Here, N is the number of theoretical plates, L is the length of the column, and 
H is the is the height of the theoretical plates. H can be calculated using the Van 
Deemter equation (3).  












Here, λ is particle shape, dp is particle diameter, γ, ω, and R are constants, Dm 
is diffusion co-efficient of the mobile phase, df is the film thickness, Ds is the 
diffusion co-efficient of the stationary phase, and u is the linear velocity. According 
to the Van Deemter equation, the resolving power of the column can be increased 
by reducing the stationary phase particle size. However, the back pressure in the 
column significantly increases due to decrease in particle size. Therefore, to 
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enable using smaller particle for improved resolving power, UHPLC can be an 
alternative for conventional HPLC. UHPLC systems possess modified pumping 
facility to exert higher pressure to overcome the back pressure of the column due 
to smaller particles.  
Resolution can be defined as the matric of how distinguishable two 
chromatographic peaks are resolved from each other. The resolution of a 
chromatographic separation can be described by fundamental chromatographic 
mechanisms via the fundamental resolution equation, equation 4.  
𝑅𝑠 =  
1
4







Here, Rs is resolution, N is the number of theoretical plates, α is selectivity and 
k is the retention factor. k is a function of retention time (t) and α is the ratio of 
retention time of two separate peaks. Getting better resolution is a trade-off with 
analysis time. Increase in number of theoretical plates, better selectivity and longer 
retention time improve resolution at the expense of longer analysis time.  
To establish the elution time of epinephrine under a certain method, pure 
epinephrine standard solutions need to be injected. Same elution profile of pure 
epinephrine at different concentrations can undoubtably establish the elution time. 
By carefully selecting the concentration range of the pure epinephrine standards, 
a calibration curve can be established. The calibration curve can be used to 
estimate the available epinephrine in the EAI samples. 
1.2.5 Quantitative smartphone imaging 
Smartphone imaging has offered a variety of point-of-care applications since it has 
emerged. All modern smartphones are equipped with a digital camera to capture 
still and motion pictures without using any films. Almost all smartphone camera 
has a CMOS sensor to process the light irradiated on it. CMOS stands for 




Figure 11: Quantitative image analysis through RGB stacking 
 
 
Each pixel is equipped with the charge to voltage converter and voltage 
amplification systems. Light passes through the lens of the digital camera and 
irradiates the pixels on the CMOS sensor. Light received by each pixel generates 
proportional amount of charge which is converted to voltage. A voltage amplifier 
inside each pixel amplifies the voltage before transferring to the readout meter. 
A Bayer filter is an array used in typical CMOS sensors for placing red, green, 
and blue color filters on square array of photosites [85]. The filter array is a 
combination of 25% red layer, 50% green layer, and 25% blue layer.  A single pixel 
is aligned with only one of the filter layers. Therefore, the true color of a single pixel 
cannot be inferred from the raw data. Demosaicing algorithms are used to assign 
red, green, and blue component values of each pixel. Each of the components has 
a value range from 0 to 255 in a typical 8-bit system. The value of each color 
component is combined to portray a compound color. If a pixel is exposed to no 
light, all three components will have a value of 0. If a pixel is exposed to white light, 
all three components will have a value of 255. Any other color will have a 
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combination of values within the range depending on the pixel being exposed to a 
color of light. This image processing technique can be utilized to conduct 
quantitative study on colored samples. If a sample contains a certain molecule or 
impurity which is responsible for the color it possesses, then analyzing the color 
pattern may be correlated with the concentration of the colored substance.  
In this study, 23 expired and degraded EAIs have been investigated for 
available dosage of epinephrine. Most of the samples had discoloration due to the 
degradation and pure epinephrine drug appears as a clear solution. The increment 
of the discoloration is hypothesized to be an indicator of the available epinephrine 
in the solution. In Figure 11, an image of an EAI sample is shown. The image has 
been disintegrated to its RGB components. Since the discoloration due 
degradation in the samples exerts a brownish color, the sample should highly 
absorb the colors of the blue end of the visible spectrum and reflect the colors of 
the red end of the visible spectrum. Therefore, if the values of the blue component 
are considered and correlated with the epinephrine concentration of the samples, 
a calibration curve can be established and utilized to estimate the epinephrine 
concentration of unknown samples.  
Smartphones are a nearly ubiquitous technology in the modern world. 
Therefore, using a smartphone camera for quantitative analysis of life-saving drugs 
in austere situations can be an easily accessible alternative to complex and 
expensive techniques. Using a smartphone as a quantitative analysis tool also 
makes the process portable and robust. The functionality of a modern smartphone 
perfectly aligns with the motivation of this study and achieves the analytical goal 
of the study. 
1.2.6 Summary 
Background concepts regarding to our point-of-care epinephrine estimation 
method are discussed in this section. The section includes brief discussion about 
anaphylaxis indicating the symptoms, mechanism, and treatments. Brief 
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discussions about measuring epinephrine through conventional HPLC and 
alternate quantitative point-of-care method are also included in this section. 
1.3 SCXC based immunoassay 
1.3.1 Objective 
The U.S. Centers for Disease Control reported a 29% increase in the 
prevalence of Autism Spectrum Disorder (ASD) among 8-year-old children from 
2008 to 2012 [86]. ASD affected children suffer from impaired social, emotional 
and language development. The dynamic secretion of oxytocin in the 
hypothalamus is strongly correlated with the development and expression of these 
characteristics, and endogenous opioid peptides, such as β-endorphin, are known 
to have a complex regulatory relationship with oxytocin secretion. There is a lack 
of knowledge of the secretion dynamics of these hormones which prevents an 
accurate understanding of the regulatory relationship between oxytocin and β-
endorphin. To facilitate the study of their secretion dynamics, new bioanalytical 
assays are needed to enable the measurement of these hormones at low 
concentrations in small volumes. This capability will enable the study of hormone 
secretions at biologically relevant concentrations (high pM to low nM) and with 
spatial resolution via ex-vivo slice culture.  
The working hypothesis for this project is that SCXC can improve the 
separations required for direct homogeneous immunoassays. To test this 
hypothesis, immunoaffinity reaction between antigen (oxytocin or β-endorphin) 
and a fluorescently labeled antibody will be carried out and the immunocomplex 
will be crosslinked. SCXC separation of the crosslinked complex from unbound 
antibody will be carried out to quantify oxytocin and β-endorphin in complex sample 
matrices. Completing this project will enable a novel non-competitive 
immunoassay technique using SCXC to quantify low concentrations of proteins 




1.3.2 Regulatory relationship between oxytocin and  
β-endorphin 
Oxytocin is a neuropeptide produced in the paraventricular and supraoptic 
nuclei of the hypothalamus. It is dispersed in the bloodstream though the axon 
termini of the posterior pituitary gland [87]. Oxytocin secretion has long been 
known to be correlated with contraction of the uterus during childbirth and supply 
of milk afterwards [88]. Later, dysregulation of oxytocin was suggested to be 
responsible for expression of repetitive and affiliative behaviors which are 
dominant features of Autism Spectrum Disorder (ASD) [88, 89].  β-endorphin is a 
neurotransmitter secreted from the pituitary gland. It is known to act as an 
endogenous analgesic, and is secreted in high amounts during stressful events 
[90]. Opioid peptides like β-endorphin have regulatory relationships with oxytocin 
secretion which weaken during stressed situations and differ in regulations while 
observed in bovine and rodent plasma [91]. β-endorphin may play a role in the 
pathology of ASD by dysregulation of the secretion of oxytocin, which may lead to 
repetitive and affiliative behaviors observed in ASD. To better understand the 
regulatory relationships of β-endorphin and oxytocin, new tools are needed for 
modeling their secretion and measuring their concentrations in biologically relevant 
yet well controlled in vitro conditions.      
1.3.3 Immunoassays for peptide measurements 
Immunoassays exploit the specific binding of antibodies to their antigen to 
achieve high specificity detection of the antigen molecule. Thus, they are excellent 
tools to quantify a specific molecule within a complex biological sample matrix. In 
enzyme-linked immunosorbent assays (ELISA), antigens are bound to enzyme-
labeled antibodies where the enzyme activity, typically a detectable color or 
luminescence change during reaction of a substrate with the enzyme, is measured 
to determine the concentration of the antigen. ELISA was reported to measure 
plasma oxytocin to correlate it to autism and found at lower levels in affected 
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patients than controls [92]. Radioimmunoassay (RIA) work similarly to ELISA, but 
they employ radiolabeling and scintillation counting as a detection mode. RIA has 
been used to quantify plasma oxytocin levels, which were found to be higher in 
schizophrenic patients as compared to control patients [93]. Immunoassays 
performed using capillary electrophoresis (CE) were first reported in 1991 by 
Nielsen et al [94]. Capillary electrophoresis-based Immunoassays (CE-IA) offer 
fast measurements with ability to work with small sample volumes (low nL) 
presenting the opportunity for automated microfluidic CE-IA platforms. In the most 
common case, in which samples are collected via low flow rate techniques like 
microdialysis, the larger sample volumes (100s µL) and slower measurements 
(hours) required for ELISA and RIA make CE-IA a better choice when temporal 
resolution of the measurement is critical. In CE-IA, mixtures of antibody and 
antigen are injected into a fused silica capillary and separated based on their 
electrophoretic mobility under applied voltage. Both competitive and non-
competitive Capillary Electrophoresis based Immunoassay (CE-IA) were 
successfully demonstrated by Schultz and Kennedy in 1993 [95]. In noncompetitive 
immunoassays, fluorescently labelled antibodies specific for the analyte of interest 
are introduced in excess to the sample to achieve maximum binding. Increased 
concentrations of analyte in the sample increases the amount of antibody-analyte 
complex formed which is ideally observed as a resolved peak in the CE 
electropherogram. Noncompetitive CE-IA has been applied to measure Bovine 
Serum Albumin (BSA) with a limit of detection of 5nM [96]. Since CE separates 
charged species based on size-to-charge ratio, obtaining desired resolution of 
antibody and antibody-analyte complex can be difficult when they are very similar 
in size. In competitive immunoassays, a fluorescently labelled antigen reagent is 
added to compete for antibody binding with unlabeled antigen (the analyte) present 
in the sample. Increased analyte concentration decreases the ratio of bound-to-
free labeled antigen, observed as the ratio of two resolved peaks in the 
electropherogram. Clenbuterol was successfully measured by competitive CE-IA 
with a limit of detection of 2.5nM [97]. Competitive CE-IA overcomes the resolution 
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challenge of non-competitive CE-IA as the complex-bound and free labeled 
antigen will be significantly different in size. This resolution advantage comes at 
the cost of detection sensitivity, since in non-competitive CE-IA the fluorescently 
labeled antibody can be present in excess, whereas in competitive CE-IA 
concentrations of antibody and antigen must be on the order of the dissociation 
constant of the antibody-antigen complex to maintain equilibrium conditions 
necessary for binding competition. To improve the analytical performance of 
separations-based immunoassays, new approaches are needed that enable the 
high sensitivity of non-competitive immunoassays while overcoming the resolution 
limitation of non-competitive CE-IA. 
1.3.4 Analytical challenge for conventional 
immunoassays 
Capillary Electrophoresis Immunoassay offer two different modes to measure 
peptide hormones: non-competitive and competitive immunoassay. In non-
competitive CEIA, a fluorescently labeled antibody is introduced to the sample to 
bind with the analyte of interest. When an immunocomplex of the labeled antibody 
and analyte forms, the sample is injected to the capillary to separate the labeled 
antibody from the immunocomplex based on the different electrophoretic mobility 
of the species. The analytes of interest of this experiment are oxytocin and β-
endorphin. The molecular weight of these peptide hormones are 1 kDa and 3.5 
kDa respectively. The molecular weight of the antibodies used in these 
immunoassays are approximately 150 kDa. A successful non-competitive CEIA of 
the analyte molecules will require separation of 150 kDa antibody and 151 
kDa/153.5 kDa immunocomplex because only these are fluorescently detectable. 
Separation of such similarly sized molecules by capillary electrophoresis with 
desired resolution is very difficult [98]. An alternative way to measure peptide 
hormones through CEIA is the competitive mode. In competitive immunoassay, 
fluorescently labeled analyte-analog will be introduced to the sample in addition to 
an unlabeled antibody. The labelled analyte molecules are expected to compete 
31 
 
with the unlabeled analyte molecules from the sample to bind with the antibody. A 
successful competitive CEIA of the analyte molecules will require separation of 
151 kDa/153.5 kDa immunocomplex and 1 kDa/3.5 kDa analyte-analog because 
only these are fluorescently detectable. So, competitive CEIA is effective to 
improve the separation challenge faced with non-competitive CEIA. But, 
competitive CEIA has two major drawbacks. First, to ensure the binding 
competition, appropriate concentrations of labeled antigen and analyte  are 
essential which need to be in the same order of magnitude as the dissociation 
constant (KD) of the antibody [99]. If the concentrations are significantly lower than 
the KD of the antibody, the binding competition will be insufficient, and the 
equilibrium will not yield sufficient detectable free labeled analyte to deliver 
quantitative information of the sample analyte. Second, fluorescently labelling 
analyte may sterically hinder antibody-analyte interaction. Steric hindrance of 
antibody binding is specially challenging when the analyte molecule is as small as 
oxytocin. Non-competitive immunoassay can be useful for measuring low 
concentration analyte by increasing the concentration of the antibody to shift the 
equilibrium towards immunocomplex formation. To overcome the separation 
challenge of CEIA, new competitive immunoassay format involving ultra-high-
performance liquid chromatography (UHPLC) in strong cation exchange (SCX) 
mode will be developed for oxytocin and β-endorphin. 
1.3.5 Principles of ion exchange chromatography 
Ion exchange chromatography (IEC) separates charged species based on their 
interactions with oppositely charged stationary phase particles packed inside a 
chromatography column. Analytes are eluted by a mobile phase gradient of 
increasing concentration or varying pH, resulting in competition for stationary 
phase binding sites or alteration of the charge on the molecule, respectively. 
Cation exchange stationary phases are negatively charged and bind to positively 
charged species, whereas anion exchange stationary phases are positively 




Figure 12: Schematic representation of binding and elution in SCXC 
A. Injection of peptide mixture to a cation exchange column. The column has 
negatively charged stationary phase. B. Positive peptides bind to stationary 
phase; negative peptides remain non-retained. C. Negative peptides elute from 
column while positive peptides remain bound. D. Positive peptides elute due to 
the change of mobile phase profile (pH or Concentration change) 
 
 
stationary phases are described as either “strong” or “weak” ion exchange 
materials. Strong ion exchangers function over a wide range of pH but weak ion 
exchangers alter their charge if pH falls out of a narrow tolerance range. pH 
gradient ion exchange chromatography is a common tool for high efficiency 
separation of protein mixtures in biological samples. For example, a mixture of 
proteins (IgG, albumin, transferrin and anti Hep-B) in a sample were separated 
using ion exchange chromatography by manipulating the pH of the elution buffer 
according to the isoelectric point (pI) of the components [100]. Isoelectric point (pI) 
is the pH value at which a molecule possesses no net charge, thus pH gradients 
enable efficient elution of proteins by disrupting the ion-ion interaction of the protein 
with the stationary phase. Importantly, the starting pH of the mobile phase must be 
at least one pH unit below the pI of the molecule of interest to achieve efficient 
binding of the protein to the stationary phase [101]. Method development for IEC 
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includes choice of stationary phase, designing a suitable concentration or pH 
gradient of the mobile phase, and optimizing mobile phase flow rate. IEC can be 
employed for protein separations with exceptional resolution, for example the 
separations of two protein molecules differing by a single charged amino acid unit 
has been reported [102]. Importantly, IEC separations of high molecular weight 
(~150kDa) monoclonal antibodies like IgG1 have resolved protein isoforms that 
differ because of charge heterogeneity [103]. To facilitate faster and efficient 
separation of protein complexes for non-competitive immunoassays, new IEC 
methods specific to oxytocin and β-endorphin are needed. 
1.3.6 Summary 
Background concepts related to strong cation exchange-based immunoassay 
of beta endorphin and oxytocin are discussed in this section. Brief descriptions of 
typical analytical challenges of immunoassays and principle of strong cation 
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Conventional brain slice culture techniques, such as rotary tube or membrane 
interface culture, can maintain viable slice cultures over the course of days to 
weeks, but these techniques are poorly suited for integration with perfusion 
sampling. As a result, temporal analysis of cellular secretions using conventional 
slice culture platforms is challenging. Here, we will discuss the development of a 
microfluidic perfusion system that mimics the rotary tube technique by providing 
alternating flows of liquid nutrients and carbogen gas. The system is based on 
microfluidic bubble generation at a T-junction, in which perpendicular flows of 
aqueous media and carbogen gas produces bubbles separated by liquid droplets 
in a fashion similar to that of conventional microfluidic emulsion generators. 
Characterization of flow conditions to control bubble/droplet frequency and volume 
will be discussed. Challenges in achieving slice adhesion will be discussed, and 
the characterization of a bio-compatible polysaccharide-based glue for slice 
adhesion will be described. The system is designed for medium-to-long term 
studies of slice culture biology lasting hours to days. Fluorescent calcium imaging 
and PI/DAPI staining of cultured tissue slices of rodent hypothalamus are used to 
confirm culture viability for medium-term temporal studies. The perfusion device 
has potential for reagent flows downstream of the slice culture chamber, and the 





Ex vivo brain slice cultures are widely utilized model systems for studying 
neurophysiology [1-3]. To prepare these models, living tissue slices containing 
brain structures of interest are excised from donor animals and maintained in 
environments that provide nutrient supply and waste removal sufficient to 
substitute, at least temporarily, for the vascular perfusion no longer present in the 
excised tissue. Neuronal tissues have a particularly high oxygen demand [4],  thus 
careful consideration is needed to design tissue culture systems that provide 
appropriate oxygen supply. In the absence convection via vascular perfusion, 
oxygen transport into the tissue occurs only by diffusion, therefore gaseous oxygen 
delivery is most common as it takes advantage of higher rates of diffusion as 
compared to oxygenated aqueous media.  
An early design of a fluidic system for ex vivo slice culture is the rotary-tube 
method [104], in which tissue slices are immobilized on a planar support and 
placed in cell culture tube partially filled with culture media. The tube and planar 
support assembly are slowly and continuously rotated about the central axis of the 
tube, causing the immobilized tissue slice to be repeatedly submerged in media, 
providing nutrient supply and waste removal, then emerged into the  head space 
of the tube, providing gaseous oxygen supply. While rotary tube methods are 
particularly effective for long-term slice culture [104-110], the continuous motion of 
the system limits the ability for long-term monitoring by microscopy or 
electrophysiology. Membrane interface slice culture is an alternative approach that 
is more amenable to integration with microscopy and electrophysiology [111-113]. 
By this method, tissue is maintained on a porous membrane at the interface of 
aqueous media (below the membrane) and gaseous atmosphere (above the 
membrane), receiving simultaneous nutrient and oxygen supply from opposite 
faces of the tissue slice.  
The emergence in recent years of research into “organ-on-chip” systems has 
highlighted the value of ex vivo tissue culture for modeling complex relationships 
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in systems biology [114-120]. A key feature to these systems is the culture of cells 
and tissues in much smaller volumes of media, often with continuous perfusion, as 
compared to conventional culture methods. Microfluidic systems enable precise 
control of the culture environment, for modeling complex and dynamic biological 
stimuli, and the collection of cellular secretions with minimal dilution, for 
characterizing the response of these tissues to stimuli. The combination of precise 
environmental control and high-fidelity characterization of cellular secretions in a 
single microfluidic system can give insight into physiological phenomena difficult 
or impossible to observe by other methods [121, 122]. Importantly, the focus on 
secretion measurements in microfluidic organ-on-chip systems need not preclude 
the integration of electrophysiology [19], and often the integration of microscopy 
observations are greatly improved over conventional culture methods [123]. 
Roller tube and membrane interface culture methods utilize much larger media 
volumes than microfluidic organ-on-chip systems, complicating secretion 
measurements and motivating the design of microfluidic brain slice culture 
platforms. In the microfluidic regime, designing for adequate oxygen delivery is a 
unique challenge since flow systems are typically sealed, limiting access to 
gaseous atmosphere. Rambani and co-workers developed a novel microfluidic 
perfusion technique involving laminar interstitial flow of oxygenated aCSF to acute 
brain slices maintaining viability for 5 days [21]. The technique was also successful 
for removal of depleted medium and catabolites throughout the thickness of the 
slice. Lam and co-workers have demonstrated the ability of controlling both spatial 
and temporal variations of oxygen tension characteristic of in-vivo biology using 
microfluidic techniques [124]. The method has potential to study the importance of 
oxygen tension in the disease processes such as cancer, ischemic heart disease, 
and wound healing.   
Here, we present a new approach to microfluidic brain tissue slice culture 
based on mimicking the alternating solution and gaseous oxygen delivery achieved 
by roller tube methodologies. In this system, which we term a microfluidic “bubble 
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perfusion” device, the principles of droplet microfluidics are employed to generate 
droplets of culture media dispersed between bubbles of carbogen gas (95% O2, 
5% CO2), and brain tissue slices are perfused with the resulting monodisperse 
droplets and bubbles. The present work focuses on demonstrating viability of 
hypothalamic tissue in the microfluidic system for experiments lasting > 8 hours, 
although the system has been designed with future applications to secretion 
measurements in mind. System design and operation are discussed, fluidic 
performance is characterized, and tissue health in the perfusion system is 
demonstrated via Ca2+ imaging and propidium iodide (PI) staining. 
2.3 Experimental procedure 
2.3.1 Device fabrication 
The device was a laminated glass/PDMS structure. 750 µm thick PDMS sheets 
(Stockwell Elastomerics, Inc, Philadelphia, PA) were used as a channel layer. 
Channels were designed using AutoCAD 2019 (AutoDesk, San Rafael, CA) and 
cut using a CO2 direct-write laser cutter (VLS 2.3, Universal Laser Systems, 
Scottsdale, AZ) to form a PDMS gasket. The PDMS gasket layer was plasma 
bonded between two 75 x 25 mm microscope slides using a plasma cleaner (PDC-
001 HP, Harrick Plasma Inc., Ithaka, NY). Inlet and outlet holes were drilled on the 
surface of the chip using a Dremel rotary tool fitted with a 1 mm diameter carbide 
tipped bit. Luer ports (Cole Parmer, Vernon Hills, IL) were glued to form fluidic 
connections at the inlet and outlet holes. The tissue chamber volume was formed 
by cutting a gasket from clear VHB tape (McMaster Carr, Princeton, NJ). The VHB 
gasket was attached to the glass surface of the device and sealed using a layer of 
Gelbond film (Lonza Group LTD, Basel, Switzerland). 
2.3.2 Characterization of carbogen bubble and aCSF 
droplet 
Carbogen gas (95% O2 and 5% CO2, Airgas, Knoxville, TN) and Earl’s 
balanced salt solution (Sigma-Aldrich, Milwaukee, WI) were used as oxygen and 
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nutrient supply, respectively. Carbogen gas was delivered to the device through 
direct connection to the storage cylinder and culture media solution was delivered 
to the chip using a syringe pump (New Era Pump Systems, Inc., Farmingdale, NY). 
Droplet and bubble dimensions and frequency were characterized via smartphone 
imaging using a Motorola G5S plus and digital image analysis using Fiji software 
[125]. 
2.3.3 Synthesis of hydrogel glue 
A two-part polysaccharide hydrogel glue was synthesized and used to ensure 
tissue adhesion in the chamber. The synthesis protocol was followed as reported 
by Balakrishnan and co-workers [56]. Briefly, 5 g Dextran (Fisher Scientific, 
Suwanee, GA) dissolved in 100 mL Milli-Q purified water (Millipore, Bedford, MA) 
was oxidized in the presence of sodium metaperiodate (Fisher Scientific, 
Suwanee, GA) to dextran dialdehyde (DDA). The oxidation reaction was carried 
out for 6 hours at room temperature in dark while constantly stirring the mixture. 
The mixture was then dialyzed (MWCO = 12 KDa) for 48 hours to remove excess 
sodium metaperiodate. The dialyzed solution was tested by reaction with 1 wt% 
silver nitrate solution (Fisher Scientific, Suwanee, GA) and the lack of resulting 
precipitate indicated adequate removal of sodium metaperiodate. The dialysate 
was lyophilized and stored at 4 °C for future use. Chitosan hydrochloride (ChitHCl) 
was synthesized following protocol described in Austin and Sennett [126]. 10 g 
chitosan (Sigma-Aldrich, Milwaukee, WI) was continuously stirred in 60% ethanolic 
HCl (Fisher Scientific, Suwanee, GA) for 3 hours at room temperature. The ChitHCl 
product was filtered and washed thoroughly with 75% v/v acetone (Fisher 
Scientific, Suwanee, GA). The residue was dialyzed (MWCO = 12 KDa) and the 
absence of residual HCl was confirmed by 1 wt% silver nitrate. The dialysate was 
lyophilized and stored at 4 °C for future use. To form the final two-part hydrogel 
glue, separate 5 wt% ChitHCl and 10 wt% DDA solutions were prepared using 
phosphate buffer saline (Fisher Scientific, Suwanee, GA). 2 µL of each solution 
was mixed on the hydrophilic side of the Gelbond film immediately prior to placing 
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a tissue slice on to the glue mixture. The tissue loaded Gelbond film was then used 
to seal the perfusion chamber, as described above. 
2.3.4 Tissue slice preparation and Fluo-4 AM dye 
loading 
500 µm thick coronal tissue sections containing the suprachiasmatic nucleus 
(SCN), underlying optic chiasm, and a small area of surrounding anterior 
hypothalamus were prepared from 2-4 month old male C57/Bl mice (Envigo, 
Indianapolis, IN) that had been housed in 12:12 light-dark conditions with food 
available ad libidium, as described previously [127]. Tissue slices were initially 
placed in an interface brain slice chamber constantly perfused with EBSS (pH 7.4) 
at a rate of approximately 25 mL h-1, maintained at 37oC, and supplied with 
carbogen gas as described [127, 128]. The tissue was allowed to recover from the 
trauma of slice preparation for 1 hour.  
Tissue slices were submerged in 10 µM solution of Fluo-4 AM dye (Fisher 
Scientific, Suwanee, GA) and 1% Pluronic acid-127 (Molecular Probes, Eugene, 
OR). The Fluo-4 AM dye was diluted to the desired concentration using Earl’s 
balanced salt solution (Sigma-Aldrich, Milwaukee, WI). Slices were kept 
submerged in the dye-loading solution for 45 minutes, following the protocol 
reported by Cameron and co-workers [64].  
2.3.5 Perfusion experiment and calcium imaging setup 
To maintain the uninterrupted supply of the carbogen gas to the device, a direct 
connection between the storage cylinder and the device inlet was established. The 
flowrate of the gas was regulated by a gas regulator connected to fused silica 
capillary tubing (23 cm long, 25 µm I.D.) which provided appropriate back pressure 
and allowed control of gas flow rates by applying pressures determined by the 
Hagen-Poiseuille equation. The flowrate of the gaseous media was kept constant 
at 38 µL min-1. 
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Images of dye-loaded tissue slices were captured at fixed time interval by a 
high-resolution monochrome CMOS camera (DCC3260M, Thorlabs, Newton, NJ) 
using a lab-built epi-fluorescent microscope system. Illumination was via a 488 nm 
laser diode (L488P60, Thorlabs, Newton, NJ) transmitted to the chamber via a 490 
nm long pass dichroic mirror (DMLP490R, Thorlabs, Newton, NJ) and a 10X 
microscope objective lens (Newport Corporation, Mountain View, CA). Emission 
was collected by the same objective lens, then passed through a 515 +/- 5 nm 
bandpass filter (FL514.5-10, Thorlabs, Newton, NJ) before the image was 
captured by the camera. Images were processed and analyzed using Fiji [125]. 
The temperature of the chamber was regulated using a resistive heater powered 
by a programmable controller (TC200, Thorlabs, Newton, NJ). 
2.3.6 Propidium Iodide staining and fluorescence 
imaging setup 
To assess the tissue health in the perfusion system, the tissue slices were 
subjected to propidium iodide (PI) staining [129-132]. PI is able to enter dead and 
damaged cells due to reduced membrane integrity, after which it intercalates with 
the DNA and fluoresces upon excitation with appropriate wavelength of light (535 
nm). After Ca2+ imaging was complete, the tissue sections were perfused within 
the microfluidic chamber for 2 h with 4.6 µg/ml PI (Fisher Scientific) prepared in 
EBSS. The tissue slices were then removed from the microfluidic chamber and 
transferred to a scintillation vial containing 4% PFA and incubated for 10 mins on 
ice. After 10 mins, the PFA was replaced with a 30% sucrose solution, and the 
tissue sections were incubated overnight in at 4ºC. The following day, the slices 
were removed from the sucrose solution and embedded in optimal cutting 
temperature compound (Fisher Scientific) and stored in -80º until sectioning. The 
tissue slices were thin-cut (10 µm) with a cryostat and the sections were collected 
on gelatin-subbed slides and stored in -80º to be processed further for staining. 
For staining, the slides containing the tissue sections were first allowed to air dry 
and then washed once in phosphate buffered saline for 10 mins. After the wash, 
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the sections were coverslipped using mounting media that includes the nuclear 
stain 4′,6-diamidino-2-phenylindole (DAPI; Vectashield, Vector Laboratories, 
Burlingame, CA) and the edges were sealed using a nail-polish. Fluorescence 
images were acquired using a Leica DM6000B microscope. The images were 
analyzed using ImageJ software (NIH). Cell counts were performed on a single 
tissue section, taken near the middle of the SCN, from each tissue section. The 
images were split into blue and red channels, where the blue channel shows DAPI-
stained cells and the red channel shows PI-stained cells. The SCN region was 
identified as a region of high cell density immediately dorsal to the optic chiasm. 
The total number of cells in the identified area were counted using the blue 
channel. The PI intensity across the cells in the same region was assessed using 
the red channel. The number of high PI intensity cells corresponds to the number 
of dead and damaged cells. The percent of dead/damaged cells was then 
calculated as the ratio of high PI intensity cells to DAPI cells. 
 
2.4 Results and Discussions 
To enable a new mode of oxygen delivery in microfluidic brain slice culture, a 
microfluidic device was developed to deliver alternating carbogen gas bubbles and 
media droplets to a miniature tissue culture chamber. The top view of the 
microfluidic device is shown in Figure 13a illustrating the inlets, outlet, the tissue 
perfusion chamber. The carbogen bubbles and the media droplets perfused 
through the tissue perfusion chamber providing oxygen and nutrients, respectively. 
The perfusate droplets were collected via the outlet port. Figure 13b shows the 
exploded view of the device. The channel containing PDMS layer was sandwiched 
between two microscope slides. The tissue perfusion chamber was placed on the 
top glass slide and sealed with the hydrophilic face of the GelBond film forming the 
interior wall of the tissue chamber. 
The generation of segmented carbogen bubbles and media droplets is 
analogous to conventional droplet microfluidics techniques, albeit with a dispersing 
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phase, in this case the carbogen gas, of particularly low viscosity [133]. It has been 
shown that in similar microfluidic systems droplet and bubble dimensions are a 




Figure 13: Novel microfluidic rodent brain slice culture device 
a The top view of the slice culture chip showing i. carbogen inlet, ii. media inlet, iii. 
outlet/fractionation collection, and iv. tissue perfusion chamber with a mock 




In the present work, relatively large bubble, and droplet volumes, as compared 
to conventional microfluidic dimensions, were needed to achieve well-controlled 
perfusion behavior in the tissue chamber. Typical tissue slices were 0.5 mm thick 
with lateral dimensions of ca. 1.5 x 1 mm. The chamber was designed to allow 
convective flow around all exposed faces of the tissue slice, excluding the face 
adhered to the chamber surface. Chamber depth was 0.75 mm and overall 
chamber volume was ca. 6.75 μL. As a result, relatively large channel dimensions 
(channel width 1.6 mm) at the droplet-forming intersection were needed, and 
bubble/droplet formation was characterized at these channel dimensions (Figure 
14). 
To understand the precision with which bubble perfusion could be delivered to 
tissue slices, we characterized multiple dimensions of bubble and droplet 
generation. Bubble volume was characterized following the work of van Steijn and 
coworkers [42]. They showed that at conventional microfluidic scales bubble 
volume was well controlled via the ratio of volumetric flow rates for the gaseous 
(qg) and liquid (ql) components. We observed the same trend at larger channel 
dimensions in the current device (Figure 14a). The volume of both the bubbles and 
the droplets followed the expected trend of increasing and decreasing respectively 
with increasing qg at a constant ql(Figure 14b). A convenient approach for 
describing total liquid perfusion volumes in a system delivering segmented flow is 
to consider the duty cycle of liquid flow. Duty cycle of droplets was characterized 
at a constant ql across various values of qg (Figure 14c) and was observed to 
decreased linearly with increasing qg. Precise control of droplet duty cycle enables 
perfusion of tissue slices with dynamic and highly reproducible perfusion volumes. 
Another key consideration of perfusion dynamics was the frequency of droplet 
generation, intended to ensure adequate oxygenation over hours-long perfusion 
experiments. Bubble frequency increased linearly with qg (Figure 14d) which, along 
with the observations of droplet duty cycle, suggested that droplet and bubble 
dynamics resulted from laminar flow mechanisms as in conventional droplet 




Figure 14: Characterization of the novel microfluidic  
rodent brain slice culture device 
a The characterization of the length of the bubbles generated at the T-junction as 
a function of the ration of the gas and liquid phase volumetric flowrates (R2 = 0.99), 
b The characterization of the carbogen bubble volume (R2 = 0.91) and media 
droplet volume (R2 = 0.87) as a function of the volumetric flowrate of the carbogen 
gas, c the characterization of the duty cycle as a function of the volumetric flowrate 
of the carbogen gas (R2 = 0.98), and d the characterization of the frequency of the 
bubbles generated at the T-junction as a function of the volumetric flowrate of the 
carbogen gas (R2 = 0.98). 
 
 
dispersing phase. Importantly, at all values of qg evaluated here, observed bubble 
frequencies exceeded those common for roller tube culture techniques (typ. 1 – 2 
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gas emersions min-1), which was limited by the high droplet duty cycle that would 
result at very low values of qg.  All tissue perfusion experiments in the present work 
were conducted at 50% droplet duty cycle (ca. 4.5 bubbles min-1) to mimic the 
conditions of conventional roller tube tissue culture. The system provides 
significantly higher temporal resolution than a conventional in-vivo micro-dialysis 
technique which requires hours to accumulate enough sample for one 
measurement [134]. Controlling duty cycle and bubble frequency may offer a 
convenient mechanism to precisely model hyperoxia and hypoxia in tissue slice 
cultures, which we intend to explore further in future work.  
To model the pressure environment of a tissue perfusion experiment while 
characterizing the bubble and droplet generation dynamics shown in Figure 14, 
the tissue chamber was loaded with either non-viable tissue slices prepared from 
frozen tissue or mock tissue slices prepared from 2% agarose gel. During these 
experiments we observed two key design challenges relating to the tissue 
chamber. First, slice immobilization within the tissue chamber was difficult to 
achieve. Initially, slices were immobilized to the chamber wall using thrombin-
coagulated chicken plasma, which is a common technique utilized in roller tube 
culture [135]. When immobilized via coagulated chicken plasma, slices became 
dislodged from their mounted position and subsequently flushed into the flow 
channel within 45 minutes of perfusion (Figure 15a). We attributed this to increased 
shear forces as compared to those of a typical a roller tube experiment, and 
therefore presumed that the adhesion forces provided by the coagulated chicken 
plasma were insufficient. We investigated numerous approaches to immobilizing 
the tissue slice via physical structures that held the slice in place, but in every case 
the additional geometry within the chamber disrupted segmented flow. Although 
cyanoacrylate-based adhesives offer appropriate holding force, studies have 
shown poor cytocompatibility of these materials [136]. Ultimately, improved 
adhesion was possible by synthesizing a bio-compatible hydrogel glue first 
described by Balakrishnan and coworkers [56]. Details on the structure and 




Figure 15: Tissue adhesion 
a Unsuccessful attempt of tissue adhesion using chicken plasma and thrombin 
glue i. dislodged rodent brain slice, ii. Direction of flow, and iii. Original position of 
the rodent brain slice b Demonstration of successful implementation of 
polysaccharide-based hydrogel glue for tissue (shown in black rectangles) at i. 
beginning of perfusion, ii. 1 hour, iii. 2 hours, and iv. 3 hours.  
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information. Figure 15b shows a coronal cross section of a rodent hippocampus 
adhered to the chamber for more than 3 hours of perfusion, indicating a dramatic 
increase in adhesive performance as compared to thrombin-coagulated chicken 
plasma. Utilizing the hydrogel glue, slices routinely adhered to the chamber for the 
full duration of 10+ hour perfusion experiments with no observed indications of 
failure or fatigue. 
The second design challenge was that of maintaining monodisperse droplets 
and bubbles as the flow entered the chamber, perfused the tissue slice, and exited 
the chamber. This can also be observed in Figure 15b, in which bubbles of various 
volume and generally poorly structured segmented flow is observed throughout 
the chamber and across multiple time points. We deemed it a strict requirement to 
maintain well-structured segmented flow over the tissue slice and in the effluent 
exiting the tissue chamber for two reasons. First, ensuring that the full volume of 
each droplet and bubble transited the chamber undisrupted was essential to 
ensuring that droplet/bubble generation accurately described the volumes and 
relative durations of perfusion conditions experienced by the tissue. Second, 
maintaining segmented flow in the effluent of the tissue chamber will offer benefits 
in future applications involving downstream temporal profiling of cellular 
secretions. Droplet microfluidics have been shown to offer substantial advantages 
for decoupling the timescales of analysis from those of perfusion [137, 138], and 
we postulate that the same advantages can be achieved with this bubble-
segmented system. We intend to demonstrate this capability in future work.  
We observed irregularities in segmented flow through the tissue chamber of 
two types which we termed “bubble sticking”, and “droplet coalescence”. Bubble 
sticking referred to the tendency for small fractions of a bubble to break apart from 
the main bubble and remain trapped within the chamber, often in contact with the 
tissue slice. This phenomenon can be observed in Figure 15b panels ii – iv. In this 
case, bubbles were typically trapped for the duration of the perfusion experiment, 
even as further droplets and bubbles perfused around the trapped bubble. This 
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was not ideal for well controlled perfusion because the trapped bubble represented 
a barrier to transporting fresh oxygen and media to the adjacent region of tissue. 
Droplet coalescence occurred when a full oxygen bubble was observed to remain 
stagnant within the chamber while two or more droplets appeared to flow around 
the bubble via the wetted outer perimeter of the tissue chamber. In these cases, 
the problem typically persisted for several droplets before the trapped bubble was 
cleared by a subsequent bubble or droplet. When present, the phenomenon would 
typically recur in an irregular and chaotic manner for the duration of a perfusion 
experiment. 
Although no quantitative metrics were observed by which these irregular flow 
phenomena could be predicted or controlled, we did develop best design practices 
that effectively eliminated their occurrence. First, the use of hydrophilic materials 
within the tissue chamber was essential. This motivated the construction of the 
tissue chamber from VHB adhesive and GelBond film rather than conventional 
materials such as PMMA or PDMS. Second, droplet and bubble volumes greater 
than 50% of the chamber volume were effective at reducing both types of flow 
irregularities. Finally, the geometry of the chamber, and especially the transitional 
from flow channel to chamber, had a dramatic impact on the occurrence of these 
flow phenomena. We anticipated that a gradual, sloping transition from the narrow 
flow channel to the wider tissue chamber would produce the least disruption at the 
gas-liquid interface and thereby help maintain segmented flow. Interestingly, we 
observed that the exact opposite was true. Flow irregularities were dramatically 
reduced or eliminated in chamber designs that included an abrupt transition from 
channel width to chamber width (as shown in Figure 13a), as opposed to those 
with gradual transitions (as shown in Figure 15b). Further work is needed to 
elucidate the precise relationship between chamber design parameters and the 
ability to maintain segmented flow throughout the perfusion experiment. This is 
especially important considering that various brain slice preparations will require 




Figure 16: Fluorescence calcium imaging 
a Schematic of the epifluorescence instrument setup for Ca2+ imaging for SCN 
slice viability. The image of an SCN slice is shown in the black rectangle and b the 
response of the SCN slice through Ca2+ induced fluorescence of Fluo-4 AM dye 
due to KCl stimuli. 
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characterize these relationships and optimize chamber design for a range of 
common slice preparations. 
To demonstrate the utility of this microfluidic system for maintaining healthy model 
tissue, slices of murine hypothalamus containing the suprachiasmatic nucleus 
(SCN) were loaded with the calcium-sensitive fluorescent dye Fluo-4 before 
perfusion within the device for 8 – 10 hours. Calcium transients were induced in 
the SCN tissue by delivering a depolarizing stimulus of 30 mM KCl in culture 
medium, and fluorescence imaging was conducted via the instrumentation 
illustrated in Figure 16a. ImageJ was used to define a region of interest that 
included only SCN tissue, and grayscale value was recorded as relative 
fluorescence intensity. KCL stimuli were delivered as 32 µL injections every 30 
mins, and the concentration profile of stimulus delivery was characterized prior to 
perfusion experiments using fluorescent dye injections (see appendix A, Figure 
32). Figure 16b shows a representative plot of relative Fluo-4 fluorescence vs. 
time, indicating strong calcium influxes correlated with the timing of KCl stimulus 
delivery. These robust calcium responses give qualitative indication that tissue 
remained viable in the perfusion system for the duration of perfusion experiments 
lasting typically 8 – 10 hours. We observed a high rate of success in maintaining 
viable tissue in the perfusion system, with 80% of the experiments (ntotal = 5, nviable 
= 4) showing robust calcium response for the duration of perfusion. Tissue that 
failed to show robust calcium response could, in many cases, be attributed to 
prolonged handling time during the dye loading step or while mounting the tissue 
in the chamber. 
To compare viable to non-viable perfusion experiments in a semi-quantitative 
manner, we conducted propidium iodide/DAPI co-staining on representative tissue 
samples that showed no calcium and robust calcium responses (Figure 17a and 
Figure 17b respectively). The circled regions represent SCN tissue, blue 
represents nuclei stained with DAPI, and dead cells are stained pink by propidium 




Figure 17: PI/DAPI staining 
Fluorescent micrographs of DAPI/PI co-stained hypothalamic tissue slices after 8 
– 10 hours of bubble perfusion. a Tissue for which no calcium transients were 
observed b Tissue that demonstrated robust calcium response throughout the 
perfusion experiment. Circles indicate the regions of analyzed as SCN tissue.   
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shows approximately 25 dead cells for every 100 total cells within the SCN. For 
tissue that showed robust calcium response, these numbers are approximately 7 
dead cells for every 100 total cells. This study indicates that robust calcium 
response in the SCN is likely correlated with overall cell viability in the region.  
2.5 Conclusion 
Microfluidic organ-on-chip technologies are emerging as valuable tools for 
modeling complex biological systems under well-controlled conditions. The culture 
of brain tissue slices in microfluidic systems presents unique challenges, including 
that of providing adequate oxygen delivery. In the present work, a novel 
microfluidic perfusion system for brain tissue slice culture was designed and 
demonstrated. This system takes inspiration from both roller-tube tissue culture 
methods and droplet microfluidic devices to perfuse tissue slices with well-defined 
volumes of culture media and gaseous oxygen as monodisperse droplets and 
bubbles.   
Via calcium imaging and DAPI/propidium iodide co-staining, this work 
demonstrated that the microfluidic perfusion system can maintain viable tissue 
slices throughout perfusion experiments lasting 8 – 10 hours. Importantly, these 
experiments were not limited by physiological concerns for the tissue, thus tissue 
viability in the perfusion system may last longer than these durations. While this 
work has demonstrated a novel system for tissue perfusion with unique operational 
advantages, substantial work in this area remains. Tissue chamber design plays 
an important and thus far poorly understood role in maintaining appropriate 
segmented perfusion, and unique geometries are likely needed for various tissue 
preparations. Importantly, the maintenance of segmented flow throughout 
perfusion has unique advantages for tissue secretion measurements, but further 
work is needed to demonstrate the utility of this system for such application. We 
intend to address these in future work outlining the continued development of this 
tissue perfusion platform. Still, this work represents an important proof-of-principle 
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for droplet and bubble perfusion as a technique for providing appropriate nutrient 
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Epinephrine autoinjectors (EAIs) are important first aid medications for treating 
anaphylaxis. A 10-fold price increase over the past 12 years, and evidence that 
expired EAIs may still contain significant doses of available epinephrine, have 
motivated interest in the efficacy of expired EAIs as treatments of last resort. 
Degradation of expired EAIs, which can be caused by improper storage conditions, 
results in various degrees of discoloration of the epinephrine solution. Previous 
studies have determined that significant epinephrine remains available in expired 
EAIs, but these have only considered EAIs that show no discoloration. Here, we 
investigate the potential for colorimetric estimation of available epinephrine dose 
based on the degree of discoloration in expired EAIs. The correlation of available 
epinephrine dose and time since expiration date was poor (r = -0.37), as 
determined by an industry standard UHPLC protocol. Visible absorbance of the 
samples integrated across the range 430 - 475 nm correlated well with available 
epinephrine dose (r = -0.71). This wavelength corresponds to the blue channel of 
a typical smartphone camera Bayer filter. Smartphone camera images of the EAI 
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solutions in various illumination conditions were analyzed to assign color indices 
representing the degree of discoloration. Color index of the samples showed 
similar correlation (|r| > 0.7) with available epinephrine dose as that of visible 
spectrophotometry. Smartphone imaging colorimetry is proposed as a potential 
point-of-use epinephrine dose estimator for expired and degraded EAIs. 
3.2 Introduction 
Epinephrine is widely used as a first aid drug for the treatment of anaphylaxis 
[139, 140]. Anaphylaxis can be triggered by a wide variety of stimuli including food, 
medication, and envenomation [141-145]. Anaphylaxis shows signs of 
hyperallergic reactions in quick successions and can lead to death [146, 147]. 
Epinephrine induces vasoconstriction which helps reduce or prevent upper airway 
mucosal edema, hypotension, and shock. Epinephrine also has important 
bronchodilator effects that help relieve laryngospasm and bronchospasm and 
cardiac inotropic and chronotropic effects, which also helps in treating hypotension 
and shock [146]. Fatality in cases of anaphylaxis is correlated with delayed 
epinephrine administration [147]. Immediate recognition of anaphylaxis and ability 
to administer epinephrine are vital to saving lives in cases of anaphylaxis, which is 
why many people prone to severe allergic reaction, as well as first aid providers, 
carry epinephrine autoinjectors (EAIs). Still, studies suggest that underuse of 
epinephrine as a first aid drug in cases of anaphylaxis is a significant problem 
[148]. 
EAIs typically contain 1 mg mL-1 epinephrine (0.5 mg mL-1 for EpiPen Junior) 
in saline solution, and are marked with expiration dates after which administration 
of the drug is not recommended [149]. Recent price increases of commercial EAIs 
have triggered interest in the efficacy of expired EAIs. In 2007, average EAI price 
increased 545% to $350 [66] and by 2016 the price was $600 [67]. A study on 
patient compliance reported that even patients with high awareness of EAI 
expiration date may still carry expired EAIs and delay replacement [68, 69]. 
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Several studies have found 50-90% active ingredient still available in EAIs from 1-
90 months after their expiration dates [70, 150, 151].  
Epinephrine oxidizes in the presence of atmospheric oxygen, taking on a pink 
to brown appearance depending on the extent of oxidation [152]. Similar 
degradation of EAI contents was observed after prolonged heat exposure [153]. 
In-depth study on effect of oxidation on drug degradation is absent because such 
effects can be well managed via proper storage of drug containers by keeping 
them away from light, heat, and atmospheric oxygen [154]. Additionally, drugs 
susceptible to oxidation are often formulated with antioxidant agents. For example, 
EAIs contain inert sodium metabisulfite which is a widely used antioxidant used in 
numerous drugs [155]. Therefore, degradation of epinephrine in EAIs can be 
attributed to poor storage conditions and prolonged exposure to light, heat, and 
atmospheric oxygen. There is evidence to suggest that epinephrine degradation 
products are well tolerated in the body. Ocular epinephrine drugs can cause 
pigmentation of conjunctiva [156, 157] and cornea [84, 156-159] due to 
epinephrine degradation products produced upon light exposure [160, 161]. The 
oxidized derivative of epinephrine is melanin-like adrenochrome [83, 84], and the 
resulting discoloration of the eye is tolerated as a side-effect of ocular epinephrine 
drugs [161]. Although it is advised to not use discolored EAIs [70, 149, 150], the 
prevalence of expired EAIs due to cost pressures, and the nature of epinephrine 
as a drug of first aid, presents the possibility that expired and discolored EAIs can 
be the only option available in emergency and remote settings.   
Austere medicine is the practice of medicine in resource-constrained 
environments, from wilderness areas in North America to third world countries 
[162]. In austere environments the ability to procure fresh medicine can be 
severely hampered, and the conundrum of using whatever medicine is available 
becomes the issue. Epinephrine is a life-saving drug for patients experiencing 
anaphylaxis and, if the medicine is discolored or out of date, waiting for 
replacement epinephrine may not be a viable option. The safety and efficacy of 
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expired and discolored EAIs is not well established, and the current accepted 
practice is that discolored EAIs should not be administered. Still, austere medical 
scenarios exist in which discolored medication will be administered, and in such 
cases the ability to assess the concentration of epinephrine in discolored or expired 
EAIs using ubiquitous and readily available smart phone technology may save 
lives. 
Simons and coworkers determined the available active ingredient in expired 
EAIs [70]. 28 EpiPens and 6 EpiPen Juniors were investigated via 
spectrophotometry and HPLC. Nearly all samples were colorless and free from 
precipitates, and all contained at least 50% of the intended epinephrine dose. They 
concluded that using an expired EAI during an emergency outweighs the potential 
risk of giving no treatment, presuming no signs of degradation are observed [70, 
163].  These studies did not consider extensively expired EAIs that showed 
substantial degrees of discoloration. 
Smartphone imaging is emerging as an approach to colorimetric detection for 
quantitative analysis. Blood glucose concentration in diabetic patients [164], 
electrolytes concentration in human sweat [165], and alkaline phosphate 
concentration in dairy [166] and serum [167] samples have been quantified via 
smartphone images.  Smartphone imaging has also been utilized in applications 
such as detecting nucleic acids [168], influenza virus counting[169], immunoassay 
of prostate specific antigens [170], and detection of Hg2+ via smartphone 
fluorescence microscopy [171-173]. 
We hypothesized that discolored EAIs present the opportunity for simple 
colorimetric estimation of the available epinephrine dose by quantitative 
smartphone imaging, which may facilitate the evaluation of EAIs at the point of 
care. Here, we investigated expired EAIs showing various degrees of discoloration 
with the objectives of 1) Determining the correlation between available epinephrine 
and the time elapsed since expiration date; 2) Determining the correlation between 
available epinephrine and the degree of discoloration; and 3) Developing a simple 
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colorimetric methodology that utilizes smartphone imaging to estimate available 
epinephrine dose in discolored EAI solutions.  
3.3 Experimental section 
3.3.1 Reagents and materials 
Epinephrine, methanol, 1-octanesulfonic acid, 1 mL polypropylene syringes, 
and 0.22 µm nylon syringe filters were from Fisher Scientific (Suwanee, GA). All 
aqueous solutions were prepared with 18.2 MΩ water from Milli-Q purification 
system (Millipore, Bedford, MA). The Luna C18 chromatography column (50 x 4.6 
mm, 5 µm particle size, 100 A0 pore size) was from Phenomenex Inc (Torrance, 
CA).  
3.3.2 Expired EAI samples 
Multiple EAIs were obtained from various sources. Expired EAIs were 
requested, without reference to storage, and it is assumed that most, if not all the 
EAIs, were carried by patients or EMS in non-temperature-controlled 
environments. After receipt of the EAIs, all syringe units were carefully removed 
from their delivery unit, placed in sealed Falcon tubes, and stored at room 
temperature until assayed. Researchers developing the protocols and analyzing 
the epinephrine samples were blinded to the expiration date until after analysis. 
These samples represent a real-world scenario of EAI storage rather than using 
EAIs from controlled environments. Time since expiration date for all the EAIs 
ranged from 12 to 207 months. 
3.3.3 Epinephrine measurements by UHPLC 
The samples were filtered through 0.22 µm nylon syringe filters to eliminate any 
particulates. The filtrates were diluted to 20% of original concentration with 50% 
methanol in water solution. Epinephrine concentrations were determined using an 
Agilent 1290 infinity series (Agilent Technologies, Inc, Santa Clara, CA) Ultra-High 
Pressure Liquid Chromatography (UHPLC) instrument equipped with a diode array 
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detector following a US Pharmacopeia (USP) standard protocol [174]. Briefly, 
isocratic elution was conducted on a C18 column at 1 mL min-1 with a mobile phase 
of 1:1 Methanol:Water with 0.1% 1-octanesulfonic acid added as an ion pairing 
agent. UV absorbance was recorded at 278 nm. Epinephrine standard solutions 
were used to produce a calibration curve in the range from 0.01 – 1.00 mg mL-1. 
The concentrations of epinephrine in EAI samples were determined by fitting the 
resultant peak area to the best fit line of the calibration data.  
3.3.4 Characterization by UV-Vis spectrophotometry 
UV-Vis spectra of the EAI samples were obtained using a NanoDrop One 
spectrophotometer (Thermo Fisher Scientific, Waltham, MA). The absorbance 
maximum of 278 nm for epinephrine was determined using epinephrine standard 
solutions, and a calibration curve was constructed in the concentration range of 
0.01 to 1.00 mg mL-1. EAI samples were diluted to 20% of original concentration 
to fall within the calibration range. Epinephrine concentrations for expired EAI 
samples were determined via absorbance at 278 nm by fitting to the best fit line of 
the calibration data.  
3.3.5 Quantitative smartphone imaging 
Color index was defined as the integrated absorbance of the spectral region 
430-475 nm, which corresponds to the blue bandpass component of a common 
photographic Bayer filter [175]. Smartphone images of the EAI samples were 
obtained with a Motorola G5S plus device. The Open Camera android application 
(http://opencamera.org.uk) was used to hold white balance and exposure time 
constant for all images taken under a particular lighting condition. EAI samples 
were imaged within standard 1 mL polypropylene syringes in four different lighting 
conditions: ambient sunlight, fluorescent office illumination with smartphone 
flashlight, fluorescent office illumination without smartphone flashlight, and under 




3.4 Results and discussion 
 
 
Figure 19: Epinephrine quantitation by UHPLC 
Representative chromatograms of a pure epinephrine standards, b expired EAI 
sample that appeared black, c expired EAI sample that appeared brown, d expired 
EAI sample that appeared pink, e expired EAI sample that appeared clear, and f 
Poor correlation (r=-0.37) was observed for epinephrine concentration in expired 




Twenty-three expired EAIs, ranging from 12 to 207 months past expiration date, 
were characterized to determine available epinephrine dose. UHPLC analysis of 
epinephrine standard solutions via a standardized USP protocol gave a peak at 
2.86 ± 0.01 minutes (Figure 19a). The EAI samples were observed as a range of 
colored solution from clear to black, and were qualitatively categorized into four 
groups, Clear, Pink, Brown, and Black, based on their appearance to the naked 
eye. Figure 19b, Figure 19c, Figure 19d , and Figure 19e shows representative 
chromatograms of samples from each qualitative category. All samples showed a 
peak at approximately 2.9 minutes, indicative of available epinephrine in the EAI 
solution. Increasing color intensity correlated with an increase in additional peaks 
eluting in the range of 1 – 2 minutes. We postulate that these additional peaks are 
epinephrine degradation by-products, although further study is needed to identify 
these constituents. EAI samples were evaluated by UHPLC in triplicate to yield 
concentration determinations with RSD < 5% in all cases. In this study, epinephrine 
concentrations in expired EAIs were found to be in the range of 0.05 – 1.43 mg 
mL-1 (See appendix A, Table 3). Although it was unexpected to observe 
epinephrine concentrations higher than the reported dose of 1 mg mL-1, and the 
nature of this discrepancy is not immediately clear, this finding corroborates those 
of Simons and coworkers who measured epinephrine concentrations as high as 
1.19 mg mL-1 [70]. We found that time since expiration date was a poor predictor 
of available epinephrine dose in discolored EAIs. Simons and coworkers found a 
Pearson correlation coefficient (r) of -0.63 indicating moderate correlation between 
available epinephrine dose and time since expiration date in expired EAIs that had 
been stored appropriately to prevent sample discoloration and formation of 
particulates [70]. For discolored EAI solutions, we observed poor correlation (r = -
0.37) of available epinephrine dose with time since expiration date (Figure 19f). 
As an initial investigation into the efficacy of photometry for EAI 
characterizations, epinephrine concentrations were determined by UV-Vis 
spectrophotometry of the same filtered EAI samples used for UHPLC 




Figure 20: Epinephrine quantitation by UV spectrophotometry 
a Representative UV absorbance spectrum of discolored EAI samples and an 
epinephrine standard solution at 0.4 mg mL-1, b Comparison of epinephrine 
concentrations determined by UV spectrophotometry vs. those determined by the 
industry standard UHPLC protocol, and c Residual plot of epinephrine 
concentrations of EAI samples from UV spectrophotometry vs concentrations 
determined by UHPLC  
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representative samples shown in Figure 19b through Figure 19e, with an additional 
trace showing an epinephrine standard solution of concentration 0.4 mg mL-1. EAI 
epinephrine concentrations were determined via calibration of UV absorbance at 
278 nm.  
Figure 20b shows the comparison of epinephrine concentrations determined 
by UV spectrophotometry with those determined by the standard UHPLC protocol. 
UV absorbance consistently overestimated epinephrine concentrations, which is 
evident from the mostly positive residual values shown in the residual plot of Figure 
20c. We hypothesize that the inaccuracy of UV-absorbance in determining 
epinephrine concentration is a result of spectral overlap between degradation 
products in solution and epinephrine, which is supported by the observation of non-
epinephrine peaks in the chromatograms of degraded EAI samples with 
absorbance detection at 278 nm (see Figure 19b through Figure 19e). Importantly, 
UV-absorbance was measured using filtered samples, which eliminated particulate 
matter and had the effect of reducing, although not eliminating entirely, the 
intensity of discoloration as observed by the naked eye. Filtration was necessary 
prior to UHPLC and was convenient for avoiding aberrant scatter in UV 
absorbance measurements, but it poorly approximated the conditions of expired 
EAI solutions at the point of use. 
We hypothesized that colorimetry of the unfiltered, and thus more intensely 
colored, expired EAI samples would yield a more effective correlation with 
epinephrine concentration. Unfiltered samples appeared with various red hues 
ranging from pink to dark brown, thus we investigated absorbance in the blue 
region of the visible spectra. Figure 21a shows the UV-Visible spectra in the range 
175 – 850 nm and an enlarged view of the range 430 - 475 nm (inset), which 
corresponds with the typical bandpass range of the blue component of a Bayer 
filter found in many digital cameras [176]. The trend of integrated absorbance 
across the range 430 - 475 nm corresponded with the trend of discoloration 




Figure 21: Visible Spectrophotometry of discolored EAI solutions 
a Representative UV-Vis absorbance spectrum of discolored EAI samples, labeled 
by epinephrine concentration determined via UHPLC. The inset shows a magnified 
view of the visible spectra in the range 430-475 nm, and b Images of samples 










Figure 22: Relative color index vs. epinephrine concentration 
Color index correlates well with epinephrine concentration as determined by 




determined by UHPLC (given in Figure 21a color legend), whereas absorbance at 
278 nm did not show the same correlation with the trend of epinephrine 
concentrations.    
The integrated area of the absorbance spectrum from 430 nm to 475 nm was 
calculated for each sample, and we termed this value the color index. All measured 
color index values were normalized by dividing by the highest measured color 
index to give the relative color index, which has a maximum possible value of 1. 
Figure 22 shows the correlation between epinephrine concentration as determined 
by UHPLC and the relative color index value. A significant negative correlation is 
observed as characterized by a Pearson correlation coefficient of -0.71. This 
negative correlation suggests that colorimetry of the unfiltered degraded EAI 
samples may offer an effective approach for estimating epinephrine concentration.  
To demonstrate the efficacy of smartphone imaging for colorimetric assay of 
degraded EAIs, solutions were transferred into standard 1 mL polypropylene 
syringes and imaged via smartphone camera. Imaging conditions were 
standardized by utilizing a sheet of standard A4 printer paper as an imaging 
background, and multiple illumination conditions were investigated.  
Each colored image was decomposed into 3 grayscale images representing 
the red, green, and blue components (i.e. converted to “RGB stack”) using the 
open source imaging application Fiji [125]. Mean grayscale intensities from the 
blue image channel in specific regions of interest were used to determine an 
approximated color index value according to equation 5. 




where I0 is the mean grayscale intensity from a representative region of interest on 
the white background, and I is the mean grayscale intensity from a representative 
area of the syringe as indicated in Figure 23a through Figure 23d. This image 




Figure 23: Quantitative smartphone imaging 
 of discolored EAI solutions 
Representative images of EAI solutions illuminated via a ambient sunlight, b 
fluorescent office illumination with smartphone flashlight, c fluorescent office 
illumination without smartphone flashlight, and d dark ambient conditions with 
smartphone flashlight illumination; Plots of relative color index vs. epinephrine 
concentration under e ambient sunlight (r = -0.77), f fluorescent office illumination 
with smartphone flashlights (r = -0.76), g fluorescent office illumination without 
smartphone flashlights (r = -0.71), and h dark ambient conditions with smartphone 
flashlight illumination (r = -0.71). Black circles in figures a-d indicate regions of 
interest that gave mean intensity values for R, G, and B as indicated in each figure. 
Note smaller regions of interest were used in panel b and d to avoid the effects of 








performed on images collected outdoors under ambient sunlight (Figure 23a and 
Figure 23e), under fluorescent office illumination with the addition of smartphone 
flashlight illumination Figure 23b and Figure 23f), under fluorescent office 
illumination without the addition of smartphone flashlight illumination (Figure 23c 
and Figure 23g), and under dark conditions while utilizing the smartphone flashlight 
(Figure 23d and Figure 23h). As with the data shown in Figure 21, all calculated 
color index values were normalized to the highest measured color index to give 
relative color index. Under all illumination conditions, similar negative correlations 
are observed between the measured color index and the epinephrine dose as 
determined via the standard UHPLC protocol, with r ranging from -0.71 to -0.77. 
Following the methodology of Watters, and coworkers [177], the calibration plots 
in Figure 23e - h were each fitted with a 95% confidence band to estimate 
confidence interval as a function of epinephrine concentration (see appendix A, 
Figure 33). The estimated 95% confidence interval at 1 mg mL-1 epinephrine 
ranged from ± 0.12 to ± 0.15 mg mL-1 for all lighting conditions studied here, 
indicating that, dependent on lighting conditions, a 12 - 15% reduction in reported 
epinephrine dose can be detected with 95% confidence. There are two important 
points to note here. First, these calibrations are intended to demonstrate proof of 
principle, and further calibration from a wider variety of sample sources is needed 
to deliver an assay with clinical utility. Second, there are no empirical limits 
established on effective epinephrine dose because epinephrine dosing for the 
treatment of anaphylaxis is not based on empirical study of dose-response 
relationship [178]. Therefore, no empirical metric exists by which to determine 
whether the demonstrated assay performance is sufficient for clinical utility. Still, 
in-date EAIs have been reported to contain in the range of 86% - 114% of stated 
epinephrine dose [70] indicating that the current assay can determine epinephrine 
dose degradation to within the accuracy of dosage of unexpired EAIs.   
A quantitative smartphone imaging assay can enable colorimetric estimation of 
epinephrine in environments where imaging conditions could be difficult to control. 




Figure 24: Influence of sample distance and orientation  
on color index determinations 
Color index values were determined for representative samples shown in Figure 
21while varying a imaging distance, and b syringe orientation with respect to the 
camera. All bars within each sample color were compared via paired two sample 
two-tailed t-test, and statistically significant differences (p < 0.05) were observed 
between the bars indicated with an asterisk (*).  
 
 
position and orientation with respect to the smartphone camera (Figure 24). Four 
representative samples of various hue (i.e. clear, pink, brown, and black in 
appearance) were studied to determine the variation of color index as a function 
of the syringe distance from the smart phone camera. We estimated that a natural 
ergonomic range of camera-sample distance for handheld image acquisition was 
15 - 45 cm, and images were recorded with the syringe placed at 7.5 cm 
increments within that range. For all images, the white background was placed 3.8 
cm behind the syringe, which we estimated as an appropriate distance to represent 
a syringe and white paper background held in the same hand approximately one-
to-two finger widths apart. Figure 24a shows small but statistically significant 
differences in color index for the clear sample only when comparing images 
recorded at 22.5 cm to those recorded at 37.5 cm (p = 0.007). Statistically 
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significant differences were observed for the brown sample when comparing 
images recorded at 30 cm to either those recorded at 15 cm (p = 0.002) or those 
recorded at 45 cm (p = 0.01), but no other significant differences were observed in 
the study of camera-sample distance. When color index values from all sample 
distances were pooled for each sample color, RSD was 4.8%, 4.3%, 4.9%, and 
2.9% for clear, pink, brown, and black samples, respectively. This result suggests 
that, despite the small significant differences observed, the imaging assay is robust 
to camera-sample distance in the range of 15 - 45 cm. 
We estimated that an operator could reasonably approximate syringe 
orientation to within ± 20° of vertical. Thus, to study the influence of syringe 
orientation, we collected sample images with syringes oriented vertically, and with 
20° of tilt in the plane of the image (i.e. left and right tilt) and out of the plane of the 
image (i.e. forward and back tilt). There were no statistically significant differences 
observed when comparing data from vertically oriented syringes with those tilted 
left or right, within the plane of the image (data not shown). This is unsurprising, 
since tilted orientation within the plane of the image does not affect the path length 
of light from the white background through the volume of the syringe. Statistically 
significant reductions in color index value (p < 0.005) were observed when 
comparing syringes tilted forward (i.e. toward the camera) with either vertical or 
backward tilted syringe images for the pink and brown samples only (Figure 24b). 
The origin of this phenomenon is not immediately clear, but we do not attribute it 
to increased path length which would increase the observed color index value. 
When color index values from all sample orientations were pooled for each sample 
color, RSD was 5.0%, 3.4 %, 4.3%, and 7.5% for clear, pink, brown, and black 
samples, respectively. Thus, the assay is robust to sample orientation when the 
syringe is oriented within ± 20° of vertical.         
3.5 Conclusions 
We investigated available epinephrine dose in expired and discolored EAIs via 
the USP standard UHPLC methodology, spectrophotometry, and quantitative 
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smartphone imaging. We found that time past expiration date is a poor predictor 
of available epinephrine concentration when EAIs have degraded and become 
discolored. Although spectrophotometry is employed for quality control in 
commercial epinephrine production [179], UV absorbance at 278 nm did not 
accurately estimate the epinephrine concentration in degraded EAIs, likely due to 
the presence of degradation products with spectral overlap with epinephrine. In 
discolored and unfiltered EAIs, visible absorbance in the range 430-475 nm 
correlated well with available epinephrine concentration, which enabled the 
development of a quantitative smartphone imaging protocol.  A simple digital 
image processing procedure utilizing smartphone images yielded a strong 
correlation (|r| > 0.7) with epinephrine concentrations determined by standard 
UHPLC protocols, and this strong correlation persisted under various lighting 
conditions. Quantitative smartphone imaging was robust to moderate variations in 
sample-camera distance and sample orientation, yielding color index 
determination with RSD ≤ 7.5% in all cases studied. 
The present work stops short of providing a point-of-use analysis tool for 
several important reasons. First, although our work demonstrates feasibility for 
quantitative imaging in various lighting conditions, a universal calibration that is 
normalized for illumination and white balance conditions is still needed. This 
presents a multivariate challenge that will form the basis of future work in this area. 
Second, although the digital image processing employed here is well within the 
computational abilities of common smartphones, in the present work digital image 
processing was accomplished offline using a personal computer. Substantial 
development is needed to package the image processing tasks along with an 
appropriate user interface into a simple-to-use smartphone application. Again, we 
intend to address this challenge with future work. Finally, and most importantly, the 
safety and efficacy of administering discolored EAI drugs is not well established. 
Although we postulate that the tolerance of discolored degradation products in 
ocular epinephrine drugs suggests low toxicity of the degradation products, this 
determination requires consideration by the wider medical community and lies well 
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beyond the scope of the present work. Still, the present work establishes two key 
findings: 1) EAI discoloration can be utilized as an indicator for approximating 
available epinephrine concentration; and 2) EAI discoloration is readily quantified 














4.1 Method development for SCXC-based 
immunoassay of β-endorphin 
An appropriate SCXC method is essential to separate antibody and 
immunocomplex for successful non-competitive immunoassay. The retention of 
any molecule in a specific cation exchange column at constant temperature 
depends on the following factors: pH of mobile phase, isoelectric point of the 
molecule, concentration of mobile phase, and flow rate of mobile phase. The 
particle size in the cation exchange column is 5 µm. All the experiments were 
carried out at room temperature. The mobile phases used in the chromatographic 
separation are phosphate buffers in the concentration range of 5 mM to 1000mM. 
The isoelectric point of the IgG antibody is in the range of 6.6-7.2. At pH 6, the 
antibody molecule has a net positive charge, but it is expected to elute earlier than 





Figure 25: Cation Exchange Chromatograms: individual injections of 






Table 1: The working method for separation of IgG antibody 
Column  Agilent Bio SCX, non-porous, 2.1 x 50 mm, 5 µm, PEEK 
Flowrate 0.35 ml/min 
Mobile phases A (phosphate buffer, pH 6, 5.5 mM) and B (phosphate 
buffer, pH 6, 1000 mM) 
Mobile phase 
gradient 




Runtime 17 mins 
 
 
Higher concentration of mobile phase A can make the IgG antibody possess a 
very short retention time making it practically non-retained in the column. Large 
number of particles in higher concentration mobile phase competes with the bound 
molecule vigorously for early elution. 20mM or higher concentration of mobile 
phase A made the IgG antibody  elute earlier than 0.2 minute while even poorly 
retained molecules should elute after 0.3 minute based on the void volume of the 
column. 5.5mM concentration of mobile phase A allowed the IgG antibody to be 
retained in the column and elute at around 0.5 min. The separation of the antibody 
and analyte proved to be successful using a working method identified by trial and 
error. Table 1 shows the working method used to obtain the chromatograms in 
Figure 25. 
Optimum flowrate maximizes separation efficiency in liquid chromatography by 
minimizing the height equivalent to theoretical plates (HETP). HETP can be 
expressed by the Van Deemter equation (6):  
𝐻𝐸𝑇𝑃 = 𝐴 +  
𝐵
𝑢




Figure 26: Flowrate optimization 
 
 
Here, A is the multiple paths term, B is the longitudinal diffusion term, C is mass 
transfer term, u is mobile phase flowrate. Higher flowrate improves the longitudinal 
diffusion term in the column but negatively affects the mass transfer term from 
mobile and stationary phase. To identify a suitable flowrate for antibody separation, 
a series of experiments were carried out following the method mentioned in Table 
1. The flowrate of the experiments was decreased gradually from 0.35 ml/min to 
0.05 ml/min and HETP was minimum at 0.10 ml/min. Figure 26 shows the change 
of HETP with the change of flowrate.  
When an immunomixture of β-endorphin and IgG antibody is injected, it is 
expected that the analyte will bind to the specific binding site of the IgG antibody 
and possess a different elution time from both the analyte and the antibody. The 
immunocomplex is expected to elute at an intermediary time to β-endorphin and 
IgG antibody retention time based on the following: when antibody binds to the 
analyte, it is likely to block solvent access to one or more (but not likely all) cationic 
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residues of β-endorphin. It is less likely that β-endorphin (3.5 kDa) blocks the 
majority cationic residues of IgG antibody (150 kDa) because of the difference in 
their molecular size. If the immunocomplex has formed without the species 
blocking each other’s cationic residue, it is expected to elute slightly later than β-
endorphin. This assumption is based on the summation of the cationic character 
of the strongly cationic β-endorphin and weakly cationic IgG antibody. Figure 25(iii) 
shows a chromatogram of the injection of immunomixture of 10:1 molar ratio of β-
endorphin and IgG antibody. It does not show any unique migration time of any 
new species other than β-endorphin and IgG antibody. Based on the evidence, it 
can be hypothesized that the immunocomplex cannot withstand the stringency of 
UHPLC-SCXC separations resulting rapid dissociation. A solution to overcome this 
challenge can be introduction of covalent cross-linking of antigen to antibody to 
use UHPLC-SCXC as a separation tool for non-competitive immunoassay of β-
endorphin. 
4.2 Crosslinking of β-endorphin to IgG antibody for 
covalent stabilization 
Crosslinking stabilizes a non-covalent complex by introducing covalent bonds 
formed between the proteins with a suitable linking reagent. Such reagents 
possess two different reactive functional groups in their structure specific for 
different functional groups in the two proteins to be crosslinked.  β-endorphin 
sequence has 5 lysine amino acids which contain primary amine functional groups. 
IgG antibodies have cysteine residues forming di-sulfide bonds to retain the 
structure of relatively large and high molecular weight molecule. Free sulfhydryl 
functional group are also found in the variable domain of the light chain of IgG 
antibody [180]. Since there are no sulfhydryl functional group in β-endorphin, it is 
convenient to use amine-sulfhydryl crosslinking reagent for β-endorphin and IgG 




Figure 27: Crosslinking of IgG antibody and antigen complex with 
amine-sulfhydryl crosslinking reagent (Sulfo-GMBS or Sulfo-SMPB).  
 
 
crosslinking procedure involves amine-sulfhydryl crosslinking reagent like Sulfo-
SMPB or Sulfo-GMBS (structures in Figure 27). Both of the crosslinking reagents 
contain sulfo-N hydroxysuccinimide ester (Sulfo-NHS ester) and maleimide 
functional groups on either ends. Sulfo-NHS ester can conjugate with primary 
amines available in the Lysine amino acids in beta-endorphin by forming amide 
bonds. In physiological pH conditions (slightly alkaline, ~7.5), stable amide bonds 
form between primary amines and Sulfo-NHS ester groups by releasing sulfo-
NHS. In similar physiological pH conditions, maleimide groups can conjugate with 
sulfhydryl groups available in variable domain of the light chain of the IgG antibody 
by forming stable thioether linkage. The spacer arm lengths of these crosslinking 
reagents are 11.6 Å and 7.3 Å respectively. First, the amine containing protein (β-
endorphin) is solvated in pH 7.0 phosphate buffer saline. Then, the amine-
sulfhydryl crosslinking reagent is added at least 10-fold molar in excess to ensure 
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binding with the amine containing protein. Excess crosslinker molecules are 
separated from the mixture by desalting column using size exclusion principle. 
Next, the sulfhydryl containing protein (IgG antibody) is added at the desired 
concentration to the mixture to complete the crosslinking. 
4.3 Minimization of equilibration time 
Strong cation exchange columns require column equilibration between 
experiments to carry out efficient separation. This limits the speed of the assay 
which has an impact to the overall success of the aim. One of the integral parts of 
aim 1 is to innovate rapid measurements of oxytocin and β-endorphin. Longer 
column equilibration period will increase time delay between experiments making 
the overall process slower than desired. The column equilibration period can be 
shortened by utilizing the features of UHPLC, for example rapid flow rates and 
gradient conditions. The Bio-SCX column used in the experiments has a 
recommended column equilibration period of 30-45 minutes. The equilibration 
period has been decreased to 15 minutes while providing similar separation 
efficiency and resolution. Both IgG antibody and β-endorphin had similar retention 




Figure 28: SCXC separation of immunomixture 
(β-endorphin and IgG antibody) 
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and β-endorphin eluted at ca. 0.5 min and ca. 6.5 min respectively in both 
experiments with different equilibration period (Figure 28). 
The equilibration period may further be decreased by faster flowrates and 
steeper mobile phase gradient. following the same protocol. In the scenario of not 
being able to have shorter equilibration period of the column to obtain desired 
separation speed, instrument modification may be done to add another SCX 
column in the UHPLC system. The proposed solution is to carry out separation in 
one column while the other one will go through equilibration protocol to become 
available immediately after the first column has completed an entire run.  
The UHPLC-SCXC experiments have been using the concentration gradient 
mode of cation exchange chromatography which elutes the bound molecule in the 
column by increasing the concentration of the mobile phase. In the scenario of the 
immunocomplex being eluted at the same period of time to either the IgG antibody 
or β-endorphin, pH gradient mode of cation exchange chromatography can be 
applied. pH gradient mode increases the pH of the mobile phase over time instead 
of increasing the concentration. The formation of the immunocomplex will possibly 
block one or more cationic site of β-endorphin and/or IgG antibody which will 
modify the isoelectric point of the complex. pH gradient cation exchange 
chromatography will ensure different migration time of the complex with modified 
isoelectric point.  
4.4 Immunoassay of β-endorphin and Oxytocin 
Following SCXC-based non-competitive immunoassay method and performing 
necessary crosslinking procedures, β-endorphin and oxytocin will be measured. 
Known concentration samples will be assayed to build up a calibration curve for 
both assays. The calibration curves for both assays will provide the information 
that how the concentration of antibody-analyte complex changes with the change 
in concentration of sample analyte. The desired limit of detection for the assays is 




Despite implementing the crosslinking protocol to establish additional covalent 
bonds between the antigen and the antibody, SCX based immunoassay failed to 
demonstrate a peak of the immunocomplex in the chromatogram. It can be implied 
the crosslinking agents were not successful to establish a stable covalent bond 
between the molecules. The functionality of the crosslinking agents is dependent 
on the spacer arm length. Spacer arm length is the physical length of the 
crosslinking agent and the  appropriate distance of the functional groups in the 
antigen and the antibody. The proposed crosslinking agents had spacer arm 
lengths of 7.3 Å and 11.6 Å respectively. The distance between the primary amine 
group in the beta-endorphin structure and the free sulfhydryl group in the antibody 
has to match the spacer arm length of the applied crosslinking agent. The failure 
of the protocol can be attributed to use of improper crosslinking agent. Several 
other crosslinking agents reactive towards primary amines and sulfhydryl groups 
with different spacer arm lengths can be used to stabilize the immunocomplex. 
Sulfo-SMCC (8.3 Å), Sulfo-EMCS (9.4 Å), Sulfo-SIAB (10.6 Å), Sulfo-LC-SPDP 
(15.7Å), PEG4-SPDP (25.7 Å), and PEG12-SPDP (54.1 Å) are potential amine-
sulfhydryl crosslinking agents with different spacer arm lengths than previously 
used. X-ray diffraction techniques can be used to determine the 3D structures of 
the antigen and the antibody to understand the relative distance of the amine 
groups in the antigen and the sulfhydryl group. The study will help choose an 
appropriate crosslinking agent to stabilize the immunocomplex. Stabilized 
immunocomplex will lead to successful immunoassays of the proposed antigens. 
An alternate postulation of inability of appearing the immunocomplex peak in 
the chromatogram maybe attributed to the inability of resolution of the antibody 
and the immunocomplex peak. The immunocomplex peak was assumed to appear 
in the intermediary zone of the antibody and antigen based on the discussion in 
4.1. Resolution of poorly resolved peaks in chromatograms can be improved by 
implementing the principles of equation 4. Further method optimization focused on 
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increasing number of theoretical plates, improving selectivity, and increasing 
retention factors may be necessary. Number of theoretical plates can be increased 
by using smaller stationary phase particles. Selectivity and retention factors can 
be improved by reducing mobile phase flowrate, which will be a trade-off with 










The work described in chapter 2 successfully reports viability of rodent SCN 
slices in the novel microfluidic perfusion device. The work has numerous future 
possible directions to improve the current device and the perfusion system. The 
current device is only intended to house SCN slices, but perfusion experiments 
can be carried out for a variety of sources of rodent brain slices. An alternate fluid 
delivery system to the continuous gas/fluid flow can be explored for simplification 
and improvement of precise stimulus delivery purpose. The prospect of changing 
the chamber geometry needs to be explored. Various sizes and shapes of the 
chamber can be characterized for seamless laminar fluid flow. The surface energy 
inside the chamber can also be characterized to improve the fluid flow. Finally, the 
modifications can be optimized to achieve seamless fluid flow and least carryover 
issues.  
5.2 Alternate fluid delivery system 
The current device uses a combination of a syringe pump and a cylinder valve 
to deliver the aCSF and carbogen gas, respectively. The current delivery system 
can generate alternate droplets of aCSF and bubbles of carbogen gas at the T-
junction of the device channels. A new approach of the fluid delivery system is 
shown in Figure 29. In all the panels of Figure 29, carbogen gas, stimulus solution, 
and aCSF media are shown to enter the device through the horizontal inlet, top 
vertical inlet, and bottom vertical inlet, respectively. In this approach, carbogen gas 
and aCSF media flow will be controlled using pneumatic valves where the duration 
of slice interaction with the bubbles and droplets can be easily controlled and 
manipulated. Instead of a continuous flow, the bubbles and droplets can remain 




Figure 29: Proposed modified fluid delivery system 
 
 
necessity. A separate pneumatic valve will be used to deliver occasional stimulus 
to the slice in lieu of aCSF media. This modification to the fluid delivery system can 
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enhance the nutrient supply, reduce reagent usage, and improve measurement 
sensitivity of consequent perfusate analysis. 
5.3 Size and shape of the device chamber 
Rodent brain slices from different regions of the brain can have a variety of 
sizes and shapes. Typical dimensions of some widely used rodent brain slices in 
culture experiments are listed in Table 2. The geometrical features of a media 
droplet changes when it enters the culture chamber from the narrower rectangular 
channels. Consequently, the droplets are prone to be disintegrated due to abrupt 
change of dimension. The droplets are also observed to remain stagnant inside 
the culture chamber if the volume is roughly < 50% of the chamber volume. 
Additionally, the shape of the chamber guides the change in length to width ration 
of a droplet. The droplets are more prone to be disintegrated if the chamber shape 
compels significant width expansion and length contraction. The size of the culture 
chamber needs to be customized according to the size of the intended tissue slice 
size. The current device uses a square shaped chamber to house the rodent brain 
slices. The square shape of the chamber was selected based on a series of 
qualitative trial and error attempts where the minimum disintegration and 
coalescence of aCSF droplets were observed. The impact of the size and shape 
of the chamber needs to quantitatively be investigated and the variables need to 
be optimized for intended tissue slices. The future work will explore all the possible 
shapes of the chamber (see appendix A, Figure 34) at different sizes quantitatively 
for seamless laminar flow of fluids and minimum carryover issues. 
5.4 Surface energy of the device chamber 
The surface inside the device chamber plays an important role for seamless 
laminar fluid flow and minimum carryover issues. In the current device, top of the 
chamber is sealed with the hydrophilic side of a GelBond film to facilitate proper 
tissue adhesion. The bottom of the chamber is the glass surface of the device. The 
bottom surface can be modified to increase or decrease the hydrophilicity and  
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Table 2: Dimensions of widely used rodent brain slices in culture 
experiments 
Regions of rodent brain slice Typical dimensions (mm x mm) 
Whole brain slice – sagittal plane [10] 12 x 8 
Hippocampus slice – coronal plane 4 x 2.5 
SCN slice – axial plane 1.2 x 1 
 
 
study its effect on the seamless laminar flow of fluids and carryovers issues. 
An additional layer of either the hydrophilic or the hydrophobic side of a GelBond 
film can be used to modify the surface energy inside the device chamber. The 
device can be alternatively fabricated using PMMA instead of glass to modify the 
surface energy. The contact angles of a droplet of water on all three proposed 
materials are shown in Figure 30. All the proposed surface materials can be 
studied to ensure seamless laminar flow of fluids and minimum carryover issues. 
5.5 Carry-over analysis 
Carryover can be defined as the remnant of aCSF from a previous droplet that 
has left the chamber. The carryover issue is particularly detrimental for perfusate 
analysis since it can alter the true concentration of the secreted molecules and 
decrease temporal resolution of the analysis. Carryover of aCSF droplets will be 
studied with respect to the changes of each variable discussed in this chapter. The 
optimized conditions for each of the variables achieving minimum carryover issues 
will be determined.  
5.6 Summary 
Achieving the goals discussed in this chapter will provide an improved version 
of the microfluidic brain slice culture device described in chapter 2. The device 




Figure 30: Contact angles of a water droplet on various surfaces 
 
 
shape. Seamless flow of media droplets will be ensured by introducing 
stagnant droplet approach and optimized surface energy inside the chamber 
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Figure 31: Tissue immobilization via physical structures 
In panel i, a clip like structure fashioned out of a GelBond film is used to hold the 
slice in the chamber. In panel ii, iii, and iv two hook like structures are fashioned 
out of GelBond films to hold the tissue in the chamber. In panel iii and iv, additional 
pool like physical structures fashioned out of PDMS and etch by hydrofluoric acid 
are introduced respectively to provide additional immobilization to the slice. In all 






Figure 32: Lag and Rise time 
a An example plot of lag time and rise time for a 300 nM fluorescence injection and 
b the estimation of the lag and rise time of the effect of stimuli delivered to the 
device. The average lag and rise time for the fluid delivery system was 92 s and 








Figure 33: Calibration plots for  
quantitative smartphone imaging experiments 
Calibration plots are shown with linear fit (red), upper (green), and lower (blue) 
bounds of the 95% confidence band of the linear fit for illumination conditions 
including a. sunlight, b. fluorescent office illumination with smartphone flashlight, 
c. fluorescent office illumination without the use of flashlight, and d. dark ambient 
light with smartphone flashlight. The full width of the 95% confidence interval as a 






































Figure 34: Slice culture chamber designs of various shapes and sizes  
i. square small, ii. square medium, iii. square large, iv. diamond small, v. diamond 






SOP for synthesis of Chitosan-Dextran based glue 
 
Part A: Preparation of Chit-HCl (chitosan hydrochloride) 
1. Weigh 10 g of high molecular weight chitosan and transfer to a 250 mL 
beaker 
2. Slowly mix 60 mL of HCl into 40 mL of ethanol in a fume hood 
3. Carefully pour the HCl-ethanol mixture into the 250 mL beaker containing 
chitosan 
4. Put a stir bar in the beaker and gently stir (100 rpm) the mixture for 3 hours 
at room temperature. 
5. After 3 hours filter off the Chit-HCl salt using a gravity filter 
6. Make a 6:2 acetone-water mixture 
7. Wash the Chit-HCl salt extensively with acetone-water mixture while still on 
the filter paper 
8. Put the Chit-HCl salt inside a dialysis tubing (MWCO 12 KDa) 
9. Tie both ends of the dialysis tubing firmly to prevent any leaks 
10. Put the dialysis tubing in a 1000 mL beaker in such a manner so that the 
bottom of the tubing does not touch the floor of the beaker. You may use 
binder clips to hold both ends of the tubing on the wall of the beaker, 
essentially making a U-shape for the tubing 
11. Fill the 1000 mL beaker with ultra-pure water (>14.1 MΩ) and put a stir bar 
in the beaker 
12. Gently stir (100 rpm) the water in the 1000 mL beaker for 2 hours 
13. Change the water in the beaker and repeat steps 11-13 for 3 times 
14. Pour 2 mL water from the 1000 mL beaker into a test tube and add a few 
drops of 1 wt% AgNO3(aq) solution. If white precipitate appears due to 
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presence of HCl in the water, repeat steps 11-14 until no precipitate 
appears. 
15. Transfer the solution from inside of the dialysis tubing to a glass vial. 
16. Freeze dry the solution 
17. Store the freeze-dried Chitosan-HCl at 4˚C until use 
 
Part B: Preparation of DDA (dextran dialdehyde) 
1. Weigh 5 g of dextran and transfer to a 250 mL beaker 
2. Weigh 4.5 g of sodium metaperiodate and transfer to the same beaker 
3. Add 100 mL of ultra-pure water (>14.1 MΩ) to the beaker 
4. Add a stir bar in the beaker 
5. Cover the beaker with aluminum foil to prevent exposure of light 
6. Stir gently (100 rpm) the mixture in the beaker for 6 hours 
7. Take 5 mL of the solution and transfer it inside a dialysis tube (MWCO 12 
KDa) 
8. Tie both ends of the dialysis tubing firmly to prevent any leaks 
9. Put the dialysis tubing in a 1000 mL beaker in such a manner so that the 
bottom of the tubing does not touch the floor of the beaker. You may use 
binder clips to hold both ends of the tubing on the wall of the beaker, 
essentially making a U-shape for the tubing 
10. Fill the 1000 mL beaker with ultra-pure water (>14.1 MΩ) and put a stir bar 
in the beaker 
11. Gently stir (100 rpm) the water in the 1000 mL beaker for 2 hours 
12. Change the water in the beaker and repeat steps 10-12 for 3 times 
13. Pour 2 mL water from the 1000 mL beaker into a test tube and add a few 
drops of 1 wt% AgNO3(aq) solution. If white precipitate appears due to 
presence of I- in the water, repeat steps 10-13 until no precipitate appears. 
14. Transfer the solution from inside of the dialysis tubing to a glass vial. 
15. Freeze dry the solution 
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16. Store the freeze-dried DDA at 4˚C until use 
 
Part C: Formation of the two-part hydrogel glue 
1. Obtain phosphate buffer saline (PBS) 
2. Hydrate Chit-HCl with PBS to form a 5 wt% solution 
3. Hydrate DDA with PBS to form a 10 wt% solution 
4. Apply 2 µL of each solution on the hydrophilic side of a GelBond film to 
adhere a typical rodent SCN slice. The volume of each part may vary for 
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